Document:

exv10w30

Exhibit 10.30

EXECUTION VERSION

TRANSFER, ASSIGNMENT AND ASSUMPTION AGREEMENT

     THIS TRANSFER, ASSIGNMENT AND ASSUMPTION AGREEMENT (this “Agreement”), dated as of
July 16, 2009, is by and between BioEnergy International, LLC, a Delaware limited liability company
(“International”), and Myriant Technologies LLC, a Delaware limited liability company
(“Myriant”).

WITNESSETH

     WHEREAS, the Board of Directors of International has resolved to undertake a corporate
reorganization pursuant to that certain BioEnergy Group Reorganization Authority Steps Memo, dated
as of the date hereof and attached hereto as Exhibit A, pursuant to which International
will transfer all of its assets related to the business or production of biofuels or specialty
chemicals (the “Specialty Chemicals Business”) to Myriant (the “Reorganization”);

     WHEREAS, pursuant to that certain Contribution and Exchange Agreement dated July 16, 2009,
Myriant owns all of the issued and outstanding membership interests of International;

     WHEREAS, in furtherance of the proposed corporate reorganization, International desires to
transfer and assign all of its assets related to the Specialty Chemicals Business, including but
not limited to those listed on Exhibit B attached hereto, but specifically excluding those
assets and liabilities listed on Exhibit C attached hereto (the “Transferred
Assets”), and Myriant desires to acquire the Transferred Assets and assume all liabilities
related to the Transferred Assets, but specifically excluding those liabilities listed on
Exhibit D attached hereto (the “Transferred Liabilities”); and

     WHEREAS, Myriant further desires to assume those certain 15% Secured Convertible Notes, with
an aggregate principal amount of $5,500,000 (the “Plainfield Note”), evidenced by that
certain Note Purchase Agreement dated October 10, 2008, by and between International and Plainfield
Direct Inc., a Delaware corporation, (as heretofore amended, the “Note Purchase
Agreement”).

     NOW, THEREFORE, in consideration of the mutual promises set forth herein and for other good
and valuable consideration, the receipt and sufficiency of which is hereby acknowledged, Myriant
and International agree as follows:

     1. Definitions. As used herein, the following terms shall have the following
meanings, which shall be equally applicable to both the singular and plural forms:

     “Agreement” has the meaning assigned such term in the introductory paragraph.

     “Capital Leases” means, in respect of any Person, all leases which shall have been, or
should have been, in accordance with GAAP, recorded as capital leases on the balance sheet
of the Person liable (whether contingent or otherwise) for the payment of rent thereunder.

 

 

          “Code” means the Internal Revenue Code of 1986, as amended from time to time, and any
successor statute.

          “Company Group” means International and its Subsidiaries.

          “Consolidated Subsidiaries” means each Subsidiary of International (whether now existing or
hereafter created or acquired) the financial statements of which shall be consolidated with the
financial statements of International in accordance with GAAP.

          “Debt” means, for any Person, the sum of the following (without duplication): (a) all
obligations of such Person for borrowed money or evidenced by bonds, bankers’ acceptances,
debentures, notes or other similar instruments; (b) all obligations of such Person (whether
contingent or otherwise) in respect of letters of credit, surety or other bonds and similar
instruments; (c) all accounts payable and all accrued expenses, liabilities or other obligations of
such Person to pay the deferred purchase price of Property or services; (d) all obligations under
Capital Leases; (e) all obligations under Synthetic Leases; (f) all Debt (as defined in the other
clauses of this definition) of others secured by (or for which the holder of such Debt has an
existing right, contingent or otherwise, to be secured by) a Lien on any Property of such Person,
whether or not such Debt is assumed by such Person; (g) all Debt (as defined in the other clauses
of this definition) of others guaranteed by such Person or in which such Person otherwise assures a
creditor against loss of the Debt (howsoever such assurance shall be made) to the extent of the
lesser of the amount of such Debt and the maximum stated amount of such guarantee or assurance
against loss; (h) all obligations or undertakings of such Person to maintain or cause to be
maintained the financial position or covenants of others or to purchase the Debt or Property of
others; (i) obligations to deliver commodities, goods or services in consideration of one or more
advance payments; (j) obligations to pay for goods or services even if such goods or services are
not actually received or utilized by such Person; (k) any Debt (as defined in other clauses of this
definition) of a partnership for which such Person is liable either by agreement, by operation of
law or by a Governmental Requirement but only to the extent of such liability; (l) the undischarged
balance of any production payment created by such Person or for the creation of which such Person
directly or indirectly received payment; and (m) any purchase money security interest in any
property, or interest therein created or assumed contemporaneously with the purchase of such
property, or interest therein, to secure or provide for the payment or financing of any part of the
purchase price thereof. The Debt of any Person shall include all obligations of such Person of the
character described above to the extent such Person remains legally liable in respect thereof
notwithstanding that any such obligation is not included as a liability of such Person under GAAP.

          “Environmental Claim” means any claim, demand, proceeding, suit, investigation, loss, cost,
expense, liability, penalty or damage arising, incurred or otherwise asserted pursuant to any
Environmental Law.

          “Environmental Law” means any and all Governmental Requirements pertaining to pollution,
protection of human health or the environment, or workplace health and safety, including without
limitation the Comprehensive Environmental Response, Compensation and Liability Act, 42 U.S.C. §
9601 et seq.; the Resource Conservation and Recovery Act, 42 U.S.C.

 

 

§ 6901 et seq.; the Federal Water Pollution Control Act, 33 U.S.C. § 1251 et seq.; the Clean Air
Act, 42 U.S.C. § 7401 et seq.; the Hazardous Materials Transportation Act, 49 U.S.C. § 1471 et
seq.; the Toxic Substances Control Act, 15 U.S.C. §§ 2601 et seq.; the Oil Pollution Act, 33 U.S.C.
§ 2701 et seq.; the Emergency Planning and Community Right-to-Know Act, 42 U.S.C. § 11001 et seq.;
the Safe Drinking Water Act, 42 U.S.C. §§ 300f through 300j-26; the Occupational Safety and Health
Act, 29 U.S.C. § 651 et seq.; and all similar Governmental Requirements of any Governmental
Authority having jurisdiction over International or its Properties or operations, and all
amendments to such Governmental Requirements and all regulations implementing any of the foregoing.

          “Equity Interests” means shares of capital stock, partnership interests, membership interests
in a limited liability company, beneficial interests in a trust or other equity ownership interests
in a Person, and any warrants, options of other rights entitling the holder thereof to purchase or
acquire any such Equity Interest.

          “ERISA” means the Employee Retirement Income Security Act of 1974, as amended, and any
successor statute.

          “ERISA Affiliate” means each trade or business (whether or not incorporated) which together
with International or its Subsidiaries would be deemed to be a “single employer” within the meaning
of section 4001(b)(1) of ERISA or subsections (b), (c), (m) or (o) of section 414 of the Code.

          “ERISA Event” means (a) a “Reportable Event” described in section 4043 of ERISA and the
regulations issued thereunder, (b) the withdrawal of International, any of its Subsidiaries or any
ERISA Affiliate from a Plan during a plan year in which it was a “substantial employer” as defined
in section 4001(a)(2) of ERISA, (c) the filing of a notice of intent to terminate a Plan or the
treatment of a Plan amendment as a termination under section 4041 of ERISA, (d) the institution of
proceedings to terminate a Plan by the PBGC, (e) receipt of a notice of withdrawal liability
pursuant to Section 4202 of ERISA or (f) any other event or condition which might constitute
grounds under section 4042 of ERISA for the termination of, or the appointment of a trustee to
administer, any Plan.

          “GAAP” means generally accepted accounting principles in the United States of America as in
effect from time to time.

          “Governmental Authority” means the government of the United States of America, any other
nation or any political subdivision thereof, whether state or local, and any agency, authority,
instrumentality, regulatory body, court, central bank or other entity exercising executive,
legislative, judicial, taxing, regulatory or administrative powers or functions of or pertaining to
government over any member of the Company Group.

          “Governmental Requirement” means any law, statute, code, ordinance, order, determination,
rule, regulation, judgment, decree, injunction, franchise, permit, certificate, license,
authorization or other directive or requirement, whether now or hereinafter in effect, including,
without limitation, Environmental Laws, energy regulations and occupational, safety and health
standards or controls, of any Governmental Authority.

 

 

          “Hazardous Material” means and includes each substance defined, designated or classified as a
hazardous waste, hazardous substance, hazardous material, pollutant, contaminant or toxic substance
under any Environmental Law and any petroleum or petroleum products that have been Released into
the environment.

          “International” has the meaning assigned such term in the introductory paragraph.

          “Lien” means any interest in Property securing an obligation owed to, or a claim by, a Person
other than the owner of the Property, whether such interest is based on the common law, statute or
contract, and whether such obligation or claim is fixed or contingent, and including but not
limited to the lien or security interest arising from a mortgage, encumbrance, pledge, security
agreement, conditional sale or trust receipt or a lease, consignment or bailment for security
purposes and any purchase money security interest in any property, or interest therein created or
assumed contemporaneously with the purchase of such property, or interest therein, to secure or
provide for the payment or financing of any part of the purchase price thereof. The term “Lien”
shall include easements, restrictions, servitudes, permits, conditions, covenants, exceptions or
reservations. For the purposes of this Agreement, International and the Subsidiaries shall be
deemed to be the owner of any Property which they have acquired or hold subject to a conditional
sale agreement, or leases under a financing lease or other arrangement pursuant to which title to
the Property has been retained by or vested in some other Person in a transaction intended to
create a financing.

          “Material Adverse Effect” means a material adverse change in, or material adverse effect on
(a) the business, operations, Property, liabilities, (actual or contingent) condition (financial or
otherwise) or prospects of the Company Group taken as a whole, (b) the ability of the Company Group
to perform any of its obligations under this Agreement, (c) the validity or enforceability of this
Agreement or (d) the rights and remedies of or benefits available to Myriant under this Agreement.

          “Material Indebtedness” means Debt or obligations in respect of one or more Swap Agreements,
of International and each of its Subsidiaries in an aggregate principal amount exceeding
$1,000,000. For purposes of determining Material Indebtedness, the “principal amount” of the
obligations of International or any of its Subsidiaries in respect of any Swap Agreement at any
time shall be the Swap Termination Value.

          “Multiemployer Plan” means a Plan which is a multiemployer plan as defined in section 3(37) or
4001 (a)(3) of ERISA.

          “Myriant” has the meaning assigned such term in the introductory paragraph.

          “Note Purchase Agreement” has the meaning assigned such term in the recitals.

          “PBGC” means the Pension Benefit Guaranty Corporation, or any successor thereto.

 

 

          “Permit” means any permit, license, authorization, registration or similar form or approval or
permission required by any Governmental Authority or pursuant to any Governmental Requirement.

          “Person” means any natural person, corporation, limited liability company, trust, joint
venture, association, company, partnership, Governmental Authority or other entity.

          “Plainfield Note” has the meaning assigned such term in the recitals.

          “Plan” means any employee pension benefit plan, as defined in section 3(2) of ERISA, which (a)
is currently or hereafter sponsored, maintained or contributed to by International, its
Subsidiaries or an ERISA Affiliate or (b) was at any time during the six calendar years preceding
the date hereof, sponsored, maintained or contributed to by International, or its Subsidiaries or
an ERISA Affiliate.

          “Property” means any interest in any kind of property or asset, whether real, personal or
mixed, or tangible or intangible, including, without limitation, cash, securities, accounts and
contract rights.

          “Redemption” means with respect to any Debt, the repurchase, redemption, prepayment,
repayment, or defeasance or any other acquisition or retirement for value (or the segregation of
funds with respect to any of the foregoing) of such Debt. “Redeem” has the correlative meaning
thereto.

          “Release” means any depositing, spilling, leaking, pumping, pouring, placing, emitting,
discarding, abandoning, emptying, discharging, migrating, injecting, escaping, leaching, dumping,
or disposing.

          “Reorganization” has the meaning assigned such term in the recitals.

          “Specialty Chemicals Business” has the meaning assigned such term in the recitals.

          “Subsidiary” means (a) any Person of which at least a majority of the outstanding Equity
Interests having by the terms thereof ordinary voting power to elect a majority of the board of
directors, manager or other governing body of such Person (irrespective of whether or not at the
time Equity Interests of any other class or classes of such Person shall have or might have voting
power by reason of the happening of any contingency) is at the time directly or indirectly owned or
controlled by International or one or more of the Subsidiaries of International, and (b) any
partnership of which International or any of its Subsidiaries is a general partner. Unless
otherwise indicated herein, each reference to the term “Subsidiary” shall mean a Subsidiary of
International.

          Swap Agreement” means any agreement with respect to any swap, forward, future or derivative
transaction or option or similar agreement, whether exchange traded, “over-the-counter” or
otherwise, involving, or settled by reference to, one or more rates, currencies,

 

 

commodities, equity or debt instruments or securities, or economic, financial or pricing
indices or measures of economic, financial or pricing risk or value or any similar transaction or
any combination of these transactions; provided that no phantom unit or similar plan providing for
payments only on account of services provided by current or former directors, officers, employees
or consultants of International or its Subsidiaries shall be a Swap Agreement.

          “Swap Termination Value” means, in respect of any one or more Swap Agreements, after taking
into account the effect of any legally enforceable netting agreement relating to such Swap
Agreements, (a) for any date on or after the date such Swap Agreements have been closed out and
termination value(s) determined in accordance therewith, such termination value(s) and (b) for any
date prior to the date referenced in clause (a), the amount(s) determined as the mark-to-market
value(s) for such Swap Agreements, as determined by the counterparties to such Swap Agreements.

          “Synthetic Leases” means, in respect of any Person, all leases which shall have been, or
should have been, in accordance with GAAP, treated as operating leases on the financial statements
of the Person liable (whether contingently or otherwise) for the payment of rent thereunder and
which were properly treated as indebtedness for borrowed money for purposes of U.S. federal income
taxes, if the lessee in respect thereof is obligated to either purchase for an amount in excess of,
or pay upon early termination an amount in excess of, 80% of the residual value of the Property
subject to such operating lease upon expiration or early termination of such lease.

          “Taxes” means any and all present or future taxes, levies, imposts, duties, deductions,
assessments, fees or other charges or withholdings imposed by any Governmental Authority, including
any interest, additions to tax or penalties applicable thereto.

          “Transferred Assets” has the meaning assigned such term in the recitals.

          “Transferred Liabilities” has the meaning assigned such term in the recitals.

          “Warrant Issuance Agreement” has the meaning assigned such term in Section 6.1(e).

     2. Transfer and Assignment. International does hereby sell, transfer, assign and
deliver to Myriant all of the rights, title and interest of International in, to and under the
Transferred Assets; provided however, that no sale, transfer, assignment or delivery shall be made
of the assumed contracts set forth in Exhibit B if an attempted sale, assignment, transfer
or delivery, without consent of a third party, would constitute a breach or other contravention
thereof or in any way adversely affect the rights of International thereunder.

     3. Acquisition and Assumption. Myriant does hereby accept all the right, title and
interest of International in, to and under the Transferred Assets and Myriant assumes and agrees to
pay, perform and discharge promptly and fully when due and to perform all of the obligations of
International to be performed under the Transferred Liabilities.

 

 

     4. Assumption of Plainfield Note. Myriant does hereby assume and agree to pay,
perform and discharge promptly and fully when due and to perform all of the obligations of
International to be performed under the Plainfield Note, subject to the consent by Plainfield
Direct Inc. of the assignment of the Plainfield Note, as required in Section 24.1 of the Note
Purchase Agreement.

     5. Representations and Warranties of International. International hereby represents
and warrants to Myriant as of the date of this Agreement and as of the consummation of the
Reorganization the following:

          5.1 Organization, Good Standing and Qualification. International is a limited
liability company duly organized, validly existing and in good standing under the laws of the State
of Delaware. International has all requisite power and authority, and has all material
governmental and third-party licenses, authorizations, consents and approvals necessary, to own and
operate its properties and assets, to execute and deliver this Agreement and to carry out the
provisions of this Agreement and to carry on its business as presently conducted. International is
duly qualified and is authorized to do business and is in good standing as a foreign limited
liability company in all jurisdictions in which the nature of its activities and of its Properties
(both owned and leased) makes such qualification necessary, except for those jurisdictions where
the failure to have such power, authority, licenses, authorizations, consents, approvals and
qualifications would not have a Material Adverse Effect.

          5.2 Changes. Since December 31, 2008, and except as set forth in Schedule
5.2, there has not been:

               (a) Any material change in the assets, liabilities, financial condition, or operations of the
Company Group from that reflected in the financial statements, other than changes in the ordinary
course of business consistent with past practice;

               (b) Any material change, except in the ordinary course of business, in the contingent
obligations of any member of the Company Group by way of guaranty, endorsement, indemnity, warranty
or otherwise;

               (c) Any damage, destruction or loss, whether or not covered by insurance, materially and
adversely affecting the properties, business or financial condition of any member of the Company
Group;

               (d) Any waiver by any member of the Company Group of a valuable right or of a material debt
owed to it;

               (e) Any direct or indirect loans made by any member of the Company Group to any of its
members, employees, officers or directors, other than advances made in the ordinary course of
business consistent with past practice;

               (f) Except in the ordinary course of business consistent with past practice, any material
change in any compensation arrangement or agreement with any employee, officer, director or member
of any member of the Company Group;

 

 

               (g) Any declaration or payment of any dividend or other distribution of the assets of any
member of the Company Group;

               (h) Any labor organization activity related to any member of the Company Group;

               (i) Any Debt, obligation or liability incurred, assumed or guaranteed by any member of the
Company Group, except those for immaterial amounts and for current liabilities incurred in the
ordinary course of business consistent with past practice;

               (j) Any sale, assignment or transfer of any patents, trademarks, copyrights, trade secrets or
other intangible assets of any member of the Company Group;

               (k) Any change in any material agreement to which any member of the Company Group is a party
or by which it is bound which materially affects the business, assets, liabilities, financial
condition or operations of any member of the Company Group;

               (l) Any mortgage, pledge, transfer of a security interest in, or lien, created by any member
of the Company Group with respect to any of its material properties or assets, except liens for
taxes not yet due or payable and liens that arise in the ordinary course of business consistent
with past practice and do not materially impair any member of the Company Group’s ownership or use
of such properties or assets.

               (m) Any arrangement or commitment by any member of the Company Group to do any of the acts
described in subsection (a) through (l) above.

          5.3 Disclosure; No Material Misstatements. International and each of its Subsidiaries
has disclosed to Myriant all agreements, instruments and corporate or other restrictions to which
it is subject, and all other matters to International’s knowledge which affect its assets,
financial condition, Properties or current operations that, individually or in the aggregate,
would, or would reasonably be expected to have, a Material Adverse Effect. None of the reports,
financial statements, certificates or other information furnished by or on behalf of International
or any Subsidiary to Myriant in connection with the negotiation of this Agreement or delivered
hereunder (as modified or supplemented by other information so furnished) taken as a whole contains
any material misstatement of fact or omits to state any material fact necessary to make the
statements therein, in the light of the circumstances under which they were made, not misleading;
provided that, with respect to projected financial information, International and each of its
Subsidiaries represent only that such information was prepared in good faith based upon assumptions
believed to be reasonable at the time.

          5.4 Governmental Consents and Filings. No consent, approval, order or authorization
of, or registration, qualification, designation, declaration or filing with, any Governmental
Authority or other third party is required on the part of International in connection with the
consummation of the transactions contemplated by this Agreement.

          5.5 Authority; Enforceability. The transactions contemplated by this Agreement are
within each member of the Company Group’s limited liability company,

 

 

corporate or partnership (as the case may be) powers and have been duly authorized by all necessary
limited liability company, corporate or partnership (as the case may be) action and, if required,
member, partner, director or stockholder action (including, without limitation, any action required
to be taken by any class of members, partners, directors or stockholders of any member of the
Company Group or any other Person, whether interested or disinterested, in order to ensure the due
authorization of such transactions). This Agreement has been duly executed and delivered by
International and constitutes a legal, valid and binding obligation of International, enforceable
in accordance with its terms, subject to applicable bankruptcy, insolvency, reorganization,
moratorium or other laws affecting creditors’ rights generally and subject to general principles of
equity, regardless of whether considered in a proceeding in equity or at law.

          5.6 Approvals; No Conflicts. Except as set forth on Schedule 5.6, the
transactions contemplated by this Agreement (a) do not require any consent or approval of,
registration or filing with, or any other action by, any Governmental Authority or any other third
Person (including members, partners, directors or stockholders, whether interested or
disinterested, of International or any other Person), nor is any such consent, approval,
registration, filing or other action necessary for the validity or enforceability of this Agreement
or the consummation of the transactions contemplated thereby, except (i) such as have been obtained
or made and are in full force and effect or, in the reasonable judgment of International, can
reasonably be expected to be obtained if so required, and (ii) those third party approvals or
consents which, if not made or obtained, would not reasonably be expected to have a Material
Adverse Effect or do not have a Material Adverse Effect on the enforceability of this Agreement,
(b) will not violate any applicable law or regulation or the charter, by-laws or other
organizational documents of the Company Group or any order of any Governmental Authority, and (c)
do not constitute with or without notice or the passage of time or both, a material violation,
breach or default, create or impose a Lien upon any Property of International, or give rise to any
right of termination, modification, cancellation, or prepayment, under (i) any applicable law or
regulation or the charter, by-laws or other organizational documents of the Company Group or any
order of any Governmental Authority, or (ii) any indenture, agreement or other instrument binding
upon International or its Properties, or give rise to a right thereunder to require any payment to
be made by International except those violations, breaches, defaults, Liens upon the Property of
International, terminations, modifications, cancellations, and prepayments which would not
reasonably be expected to have a Material Adverse Effect or do not have a Material Adverse Effect
on International, its business, assets or Properties.

          5.7 Financial Condition; No Material Adverse Effect.

               (a) Since December 31, 2008, (i) there has been no event, development or circumstance that
has had or would reasonably be expected to have a Material Adverse Effect and (ii) the business of
International and each of its Subsidiaries has been conducted only in the ordinary course
consistent with past business practices.

               (b) International has provided to its investors unaudited financial statements for the
respective quarterly periods ended March 31, 2009 and June 30, 2009, such statements which have
been prepared in accordance with GAAP consistently applied, subject to year-end audit adjustments.

 

 

               (C) International does not have on the date hereof any material Debt or any contingent
liabilities, off-balance sheet liabilities or partnerships, liabilities for Taxes, unusual forward
or long-term commitments or unrealized or anticipated losses from any unfavorable commitments,
except as disclosed on Schedule 5.7.

          5.8 Litigation and other Governmental Proceedings. Except as set forth on
Schedule 5.8, there are no actions, suits, investigations or proceedings by or before any
arbitrator or Governmental Authority pending against or, to the knowledge of International,
threatened against or affecting International or any Subsidiary (i) as to which there is a
reasonable possibility of an adverse determination that would reasonably be expected, individually
or in the aggregate, to result in a Material Adverse Effect, or (ii) that involve this Agreement or
the transactions contemplated hereby.

          5.9 Environmental Matters. Except for matters that, individually or in the aggregate,
could not reasonably be expected to have a Material Adverse Effect:

               (a) International and each of its Subsidiaries and their respective Properties and operations
are and, during the periods specified in all applicable statutes of limitation, have been in
compliance with applicable Environmental Laws;

               (b) International and each of its Subsidiaries timely applied for, possess, and are in
compliance with, all Permits required under applicable Environmental Laws for their operations as
presently conducted and such Permits are in the name of the proper entity and will remain in full
force and effect following the date hereof;

               (c) International and each of its Subsidiaries and their respective Properties and operations
are not subject to any pending or, to the knowledge of International, threatened Environmental
Claims, nor has International or any of its Subsidiaries received any written notice of
Environmental Claims;

               (d) There has been no Release of Hazardous Materials on, in, under or from the Properties by
International or any of its Subsidiaries or from or in connection with the operations of
International or any of its Subsidiaries that (i) is in violation of any applicable Environmental
Laws; or (ii) is Released or threatened to be Released in a manner that could give rise to any
remedial or corrective action obligations pursuant to Environmental Laws; and

               (e) There has been no exposure of any Person or property in connection with the operations of
International or any of its Subsidiaries that could reasonably be expected to form the basis for an
Environmental Claim or any other claim for damages or compensation.

               (f) EXCEPT AS PROVIDED IN THIS SECTION 5.9, INTERNATIONAL AND EACH OF ITS SUBSIDIARIES MAKE
NO REPRESENTATION OR WARRANTY, EXPRESS OR IMPLIED, WITH RESPECT TO ENVIRONMENTAL MATTERS.

          5.10 Compliance with Laws and Agreements; No Defaults.

 

 

               (a) International and each of its Subsidiaries are in compliance with all Governmental
Requirements applicable to them or their Properties, businesses, operations, employees, assets and
all agreements and other instruments binding upon them or their Properties, and possess all
licenses, permits, franchises, exemptions, approvals and other governmental authorizations
necessary for the ownership of their respective Properties and the conduct of their respective
businesses, except where the failure to do so, individually or in the aggregate, would not
reasonably be expected to result in a Material Adverse Effect.

               (b) International and each of its Subsidiaries are not in default nor has any event or
circumstance occurred which, but for the expiration of any applicable grace period or the giving of
notice, or both, would constitute a default or would require International or any of its
Subsidiaries to Redeem or make any offer to Redeem under any indenture, note, credit agreement or
instrument pursuant to which any Material Indebtedness is outstanding or by which International or
any of its Subsidiaries or any of its Properties is bound.

          5.11 ERISA.

               (a) Except as could not be reasonably be expected to result in a Material Adverse Effect,
International and each of its Subsidiaries have and each ERISA Affiliate have complied in all
material respects with ERISA and, where applicable, the Code regarding each Plan.

               (b) Except as could not be reasonably be expected to result in a Material Adverse Effect,
each Plan is, and has been, maintained in substantial compliance with ERISA and, where applicable,
the Code.

               (c) Except as could not be reasonably be expected to result in a Material Adverse Effect, no
act, omission or transaction has occurred which could result in imposition on International or any
of its Subsidiaries or any ERISA Affiliate (whether directly or indirectly) of (i) either a civil
penalty assessed pursuant to subsections (c), (i) or (l) of section 502 of ERISA or a Tax imposed
pursuant to Chapter 43 of Subtitle D of the Code or (ii) breach of fiduciary duty liability damages
under section 409 of ERISA.

               (d) Except as could not be reasonably be expected to result in a Material Adverse Effect, no
Plan (other than a defined contribution plan) or any trust created under any such Plan has been
terminated since the date that is six years prior to the date hereof. No liability to the PBGC
(other than for the payment of current premiums which are not past due) by International, any of
its Subsidiaries, or any ERISA Affiliate has been or is expected by International or any ERISA
Affiliate to be incurred with respect to any Plan. No ERISA Event with respect to any Plan has
occurred.

               (e) Except as could not be reasonably be expected to result in a Material Adverse Effect,
full payment when due has been made of all amounts which International, any of its Subsidiaries, or
any ERISA Affiliate is required under the terms of each Plan or applicable law to have paid as
contributions to such Plan as of the date hereof, and no accumulated funding deficiency (as defined
in section 302 of ERISA and section 412 of the Code), whether or not waived, exists with respect to
any Plan.

 

 

               (f) Except as could not be reasonably be expected to result in a Material Adverse Effect, the
actuarial present value of the benefit liabilities under each Plan which is subject to Title IV of
ERISA does not, as of the end of International’s most recently ended fiscal year, exceed the
current value of the assets (computed on a plan termination basis in accordance with Title IV of
ERISA) of such Plan allocable to such benefit liabilities. The term “actuarial present value of
the benefit liabilities” shall have the meaning specified in section 4041 of ERISA.

               (g) Neither International, any of its Subsidiaries, nor any ERISA Affiliate sponsors,
maintains, or contributes to an employee welfare benefit plan, as defined in section 3(1) of ERISA,
including, without limitation, any such plan maintained to provide benefits to former employees of
such entities, that may not be terminated by International, any of its Subsidiaries, or such ERISA
Affiliate in its sole discretion at any time without any material liability.

               (h) Neither International, any of its Subsidiaries, nor any ERISA Affiliate sponsors,
maintains or contributes to, or has at any time in the six-year period preceding the date hereof
sponsored, maintained or contributed to, any Multiemployer Plan.

               (i) Neither International, any of its Subsidiaries, nor any ERISA Affiliate is required to
provide security under section 401(a)(29) of the Code due to a Plan amendment that results in an
increase in current liability for the Plan.

          5.12 Insurance. Each of International and each of its Subsidiaries have (a) all
insurance policies (including directors and officers liability insurance) sufficient for the
compliance by each of them with all material Governmental Requirements and all material agreements
and (b) insurance coverage in at least amounts and against such risk (including, without
limitation, public liability) that are usually insured against by companies similarly situated and
engaged in the same or a similar business for the assets and operations of International and each
of its Subsidiaries. There is no material default with respect to any provision contained in any
such policy or binder, and neither International nor any of its Subsidiaries has failed to give any
notice or present any claim under such policy or binder in due and timely fashion. There are no
billed but unpaid premiums past due under any such policy or binder. Except as shown in
Schedule 5.12: (i) there are no outstanding claims under any such policies or binders and,
to the knowledge of International, there has not occurred since December 31, 2008, any event that
might reasonably form the basis of a claim against or relating to International or any of its
Subsidiaries that is not covered by any such policies or binders and (ii) no notice of cancellation
or non-renewal of any such policies or binders has been received.

          5.13 Maintenance of Properties. Except for such acts or failures to act as could not
be reasonably expected to have a Material Adverse Effect, the Properties of International and each
its Subsidiaries have been maintained, operated and developed in a good and workmanlike manner and
in conformity with all Governmental Requirements and in conformity with the provisions of all
contracts related to such Properties. All Property owned in whole or in part by International and
each of its Subsidiaries that are necessary to conduct normal operations of

 

 

International and each of its Subsidiaries are being maintained in a state adequate to conduct such
normal operations, and with respect to such of the foregoing which are operated by International
and each of its Subsidiaries, in a manner consistent with International’s and each its
Subsidiaries’ past practices (other than those the failure of which to maintain in accordance with
this Section 4.13 could not reasonably be expected to have a Material Adverse Effect).

          5.14 Swap Agreements. Schedule 5.14, as of the date hereof, and after the
date hereof, sets forth, a true and complete list of all Swap Agreements of International and each
of its Subsidiaries, the material terms thereof (including the type, term, effective date,
termination date and notional amounts or volumes), the net mark to market value thereof, all credit
support agreements relating thereto (including any margin required or supplied) and the
counterparty to each such agreement.

          5.15 Labor Matters.

               (a) No labor dispute with the employees of International or any of its Subsidiaries exists
or, to the knowledge of International, is imminent, that in each case could reasonably be expected
to cause a Material Adverse Effect.

               (b) Neither International nor any of its Subsidiaries is a party to, or bound by, any
collective bargaining agreement or any other contract with any labor union or representative of
employees.

          5.16 Books and Records. All books, records and files of International (including
those pertaining to the Properties and other assets of International, and corporate, accounting,
financial and employee records): (i) since December 31, 2008, have been reasonably prepared,
assembled and maintained in accordance with usual and customary policies and procedures, except
where the failure to so maintain such materials would not reasonably be expected to have a Material
Adverse Effect; and (ii) fairly and accurately reflect the ownership, use, enjoyment and operation
by International of the Property and other assets.

          5.17 Solvency. Both before and upon completion of the transactions contemplated by
this Agreement, (i) International’s assets, at a fair valuation, will exceed the aggregate Debt of
International and its Consolidated Subsidiaries (ii) International will be able to pay its Debts as
they become due in the ordinary course of business and (iii) International will not have
unreasonably small capital with which to conduct its business. International does not intend, in
consummating the transactions contemplated by this Agreement, to hinder, delay or defraud either
present or future creditors or any other Person to which International is or will become, after the
date hereof, indebted.

          5.18 Sufficiency of Assets. As of the date of this Agreement, the Transferred Assets
constitute all of International’s tangible assets, intangible assets, properties and rights related
to its Specialty Chemicals Business.

 

 

     6. Conditions to Closing.

          6.1 Conditions to Myriant’s Obligations. Myriant’s obligations to acquire
the Transferred Assets and assume the Transferred Liabilities and the Plainfield Note are subject
to the satisfaction, at or prior to the date hereof, of the following conditions:

               (a) Representations and Warranties True; Performance of Obligations. The
representations and warranties made by International in Section 5 hereof shall be true and correct
in all material respects as of the date hereof (except that any such representations and warranties
that are qualified by materiality will be true and correct in all respects) with the same force and
effect as if they had been made as of the date hereof, and International shall have performed all
obligations and conditions herein required to be performed or observed by it on or prior to the
date hereof.

               (b) Consents, Permits, and Waivers. International shall have obtained any and all
consents, permits and waivers necessary or appropriate for consummation of the transactions
contemplated by this Agreement, except to the extent to which failure to obtain such consent,
permit or waiver would not constitute a Material Adverse Effect.

               (c) Corporate Documents. International shall have delivered to Myriant or their
respective counsel, copies of all corporate documents of International as Myriant shall reasonably
request.

               (d) Agreement. Myriant shall have received from International executed counterparts
(in such number as may be requested by it) of this Agreement and all schedules, exhibits and
annexes hereto.

               (e) Consummation of the Warrant Issuance Agreement. That certain Warrant Issuance
Agreement, dated as of the date hereof, by and among Myriant, Plainfield Finance Corporation, Itera
Ethanol, LLC, NGP Capital Resources Company and Camulos BioEnergy Partners LLC, in substantially
the form attached hereto as Exhibit E (the “Warrant Issuance Agreement”), shall
have been executed and the transactions contemplated thereunder shall have been consummated.

          6.2 Conditions to International’s Obligations. International’s obligation to transfer
and assign the Transferred Assets to Myriant is subject to the satisfaction, on or prior to the
date hereof, of the following conditions:

               (a) Performance of Obligations. Myriant shall have performed and complied with all
agreements and conditions herein required to be performed or complied with by Myriant on or before
the date hereof.

               (b) Agreement. International shall have received from Myriant executed counterparts
of this Agreement and all schedules, exhibits and annexes hereto.

               (c) Consummation of the Warrant Issuance Agreement. The Warrant Issuance Agreement
shall have been executed and the transactions contemplated thereunder shall have been consummated.

 

 

     7. Governing Law. This Agreement shall be construed in accordance with and governed
by the law of the State of New York, without regard to the conflicts of law rules of such state.

     8. Miscellaneous. This Agreement may be executed in one or more counterparts, each of
which shall be deemed to be an original, but all of which together shall constitute one and the
same instrument.

[Signature Page Follows]

 

 

     IN WITNESS WHEREOF, the parties hereto have caused this Transfer, Assignment and Assumption
Agreement to be duly executed as of the day and year first above written.

	 	 	 	 	 	 	 

	 	 	BIOENERGY INTERNATIONAL, LLC	 	 
	 
	 	 	 	 	 	 
	 

	 	By:

Name:
	 	/s/ Stephen J. Gatto
 

Stephen J. Gatto
	 	 
	 

	 	Title:
	 	President	 	 
	 
	 	 	 	 	 	 
	 	 	MYRIANT TECHNOLOGIES LLC	 	 
	 
	 	 	 	 	 	 
	 

	 	By:

Name:
	 	/s/ Stephen J. Gatto
 

Stephen J. Gatto
	 	 
	 

	 	Title:
	 	President	 	 

[Signature Page to Transfer, Assignment and Assumption Agreement]

 

 

Exhibit A

BioEnergy Group Reorganization Authority Steps Memo

 

 

BioEnergy Group Reorganization Authority Steps Memo — July 16, 2009

Steps/Task

Step I: Completion of Plainfield and Itera International Warrant Exercise

	1.	 	Exercise of Warrants: Plainfield and Itera to exercise 178,000 and
50,000, respectively, of their $10 International warrants. International
to issue replacement warrants to Plainfield and Itera

Step II. Formation of New Limited Liability Company (“Myriant”);
Contribution by BioEnergy International, LLC (“International”) Members of
International Units to Myriant; Cancellation and Reissuance of Warrants

	2.	 	Formation of Myriant Technologies LLC: Myriant formed as a Delaware
limited liability company on April 3, 2009. Adopt initial resolutions to
appoint officers, directors, etc.
	 
	3.	 	Effect Contribution of International Units: International Holders to
effect a contribution of International Membership Units to Myriant
pursuant to a Contribution and Exchange Agreement and be issued an
equivalent number of Membership Units in Myriant.

 

 

	4.	 	Exchange International $10 Warrants for Myriant $10 Investors
Warrants: Investors to assign 3,750,000 International $10 Warrants (all
but 1,100,000 International $10 Warrants) to Myriant. Myriant to issue
3,750,000 Myriant $10 Warrants to Investors. Myriant $10 Warrants will be
allocated as set forth below:

Cancelable Warrants

	 	•	 	Itera: 243,798
	 
	 	•	 	Plainfield: 2,020,816
	 
	 	•	 	NGPC: 368,714
	 
	 	•	 	Camulos: 642,840

Non-Cancelable Warrants

	 	•	 	Itera: 0
	 
	 	•	 	Plainfield: 93,539
	 
	 	•	 	NGPC: 138,599
	 
	 	•	 	Camulos: 241,694

	5.	 	Issuance of Replacement Cancelable International $10 Warrants:
International to issue replacement cancelable $10 Warrants to Investors.
Investors will be allocated a total of 1,100,000 cancelable $10 Warrants
in the following amounts:

	 	•	 	Itera: 76,981
	 
	 	•	 	Plainfield: 636,996
	 
	 	•	 	NGPC: 140,687

 

 

	 	•	 	Camulos: 245,336

	6.	 	Exchange International $13 Warrants for Myriant $13 Warrants:
Plainfield to assign its 423,077 International $13 Warrants for an
equivalent number of Myriant $13 Warrants.

Step III. Distribution of Specialty Chemical Assets to Myriant and Assumption of $5.5 Million Note Payable

	7.	 	International and Myriant Board Consents, Investor Consent: International Board to authorize the
distribution of specialty chemical assets and Myriant Board to authorize the assumption of $5.5 million
note and liabilities related to the specialty chemical assets. Investors to consent to distribution of
assets by International and assumption of the $5.5 million note by Myriant (each Investor Consent requires
the consent of 66 2/3% of the units held by Investors). Transfer identified assets of International,
assign operating and trade liabilities and assign $5.5 million note to PFAM to Myriant through Transfer,
Assignment and Assumption agreement.

Step IV. Transfer of Ownership of Lake Providence Project from Holding to Investors and International

 

 

	8.	 	Issue New Units in Bionol Lake Providence: Bionol Lake Providence LLC to issue 99 new Membership Units
to Bionol Lake Providence Holdco. Holdco will hold 100 Membership Units (100%) in Bionol Lake Providence.
	 
	9.	 	Bionol Lake Providence Holdco Distribution of Bionol Lake Providence, LLC.: Bionol Lake Providence
Holdco to dividend 100% of the membership interests it holds it Bionol Lake Providence, LLC to BioEnergy
Holding.
	 
	10.	 	BioEnergy Holding LLC Distribution of Bionol Lake Providence, LLC Interests to International and
Investors: BioEnergy Holding to dividend 100% of the membership interests it holds of Bionol Lake
Providence LLC to International (22 units) and the Investors (78 units) in proportion to their respective
interests in Holding.
	 
	 	 	International to transfer the 22 Bionol Lake Providence units to Myriant.

Step V: Distribution of International Membership Units to Myriant Holders and Investors

	11.	 	Myriant Distribution of International Units: Myriant to dividend International Units to Myriant
Members (hereinafter, the “Unit Distribution”) in proportion to their Membership Units in Myriant.
Myriant Investors to consent to the Unit Distribution (which requires the consent of 66 2/3% of the units
held by all Investors).

 

 

Step VI: Reassign Myriant $10 Warrants Among Investors

	12.	 	Reassignment of Myriant $10 Warrants: NGPC to reassign 138,599 non-cancelable warrants and Camulos
to reassign 241,694 non-cancelable warrants to Plainfield (to receive 311,840 reassigned warrants) and
Itera (to receive 68,453 reassigned warrants) based on Plainfield and Itera’s participation in 2009
International Warrant exercise. Immediately following this reassignment, the Investors will be allocated
the following number of Myriant non-cancelable $10 Warrants:

	 	•	 	Itera: 68,453
	 
	 	•	 	Plainfield: 405,379
	 
	 	•	 	NGPC: 0
	 
	 	•	 	Camulos: 0

Step VII: Exchange of Cancelable Myriant Warrants and Lake Providence Units for Myriant Membership Units

	13.	 	Exchange of Myriant $10 Warrants and Lake Providence Membership Units for 1,000,001 Myriant
Membership Units: Investors to exchange 1,050,320 Myriant $10 Cancelable Warrants (using a Warrant
value of $2.15) and 78 Lake Providence Membership Units for 1,000,001 Myriant Membership Units.
Immediately following this exchange, the Investors will be allocated the following number of Myriant
cancelable $10 Warrants:

	 	•	 	Itera: 158,521
	 
	 	•	 	Plainfield: 1,377,697
	 
	 	•	 	NGPC: 251,372

 

 

	 	•	 	Camulos: 438,258

Step VIII: Cancellation of 1,933,333 Myriant $10 Cancelable Warrants

	14.	 	Cancellation of Cancelable Warrants: In connection with the consideration received by the
Investors in the overall reorganization, Investors agrees to have Myriant cancel 1,933,333 Myriant $10
Cancelable Warrants held by the Investors. Immediately following this step, the Investors will be
allocated the following number of Myriant cancelable $10 Warrants:

	 	•	 	Itera: 1,550
	 
	 	•	 	Plainfield: 193,903
	 
	 	•	 	NGPC: 35,379
	 
	 	•	 	Camulos: 61,682

Step IX. Issuance of Myriant $10 Warrants

	15.	 	Issuance of Myriant Warrants: Investors to reallocate $10 cancelable
Warrants such that each Investor will hold the same pro rata portion of
the Myriant cancelable warrants as they held in International. Upon
completion of this step, Myriant to issue its $10 Warrants to the
Investors in the amounts set forth below, all of which shall be
non-cancelable.

 

 

Itera: 92,203

Plainfield: 584,488

NGPC: 32,680

Camulos: 56,976

Step X. Subcontract Clearfield Management and Maintenance Agreements
from BioEnergy Management Services to Myriant/Myriant and International
to enter into Services Agreement

	16.	 	Services Agreement — Clearfield Plant: BioEnergy Management
Services to enter into a Service Agreement with Myriant in connection
with providing certain oversight services for (i) Administrative Services
and Construction Management and (ii) Operations and Maintenance, each
with the consent of Clearfield subject to a service fee.

17. International/Myriant Services Agreement: Myriant to enter into
agreement with International to provide certain services to International
on a continuing basis.

 

 

Exhibit B

Transferred Assets

Property Leases

	•	 	Quincy, MA Lease, dated September 26, 2007
	 
	•	 	Woburn, MA Lease, dated September 14, 2007
	 
	•	 	Woburn, MA Lease, Amendment #1, dated December 11, 2007
	 
	•	 	Woburn, MA Lease, Amendment #2, dated February 11, 2008
	 
	•	 	Woburn, MA Lease, Amendment #3, dated May 20, 2008
	 
	•	 	Woburn, MA Lease, Amendment #4, dated September 19, 2008
	 
	•	 	Woburn, MA Lease, Amendment #5, dated September 25, 2008
	 
	•	 	Woburn, MA Lease, Amendment #6, dated April 16, 2009
	 
	•	 	Louisiana Office Space Lease with Jay Clay Lejeune

Equipment Leases

	•	 	Alpha One Management Agreement, dated February 11, 2008
	 
	•	 	MacAir, LLC Agreement, dated February 11, 2008
	 
	•	 	Mercedes Benz Financial Lease, dated March 1, 2008
	 
	•	 	Ameridia — Electrolysis/Bipolar Membrane Unit Lease, dated February 9, 2009

Licenses

	•	 	UFRF — Lactic Acid UF #11819, dated February 2, 2006
	 
	•	 	UFRF — 1st Amendment to Lactic Acid UF #11819, dated October 6, 2006
	 
	•	 	UFRF — 2nd Amendment to Lactic Acid UF #11819, dated October 10, 2008
	 
	•	 	UFRF — 3rd Amendment to Lactic Acid UF #11819, dated June 1, 2009
	 
	•	 	UFRF — Succinic A6126, dated November 19, 2007
	 
	•	 	UFRF — Alanine A6125, dated November 30, 2007
	 
	•	 	UFRF — E.coli straings: Xylitol from Xylose UF #11804, dated November 14, 2005
	 
	•	 	UFRF — Chemicals from Lignocellulose UF #11469, dated October 3, 2005
	 
	•	 	UFRF — Efficient Production of Acetate UF #11031, dated October 3, 2005
	 
	•	 	Florida High Tech Corridor Council — UF Agreement, dated May 31, 2007
	 
	•	 	Florida High Tech Corridor Council — UF Agreement Amendment #1, dated April 10, 2008
	 
	•	 	Purac — License Agreement, dated June 26, 2006
	 
	•	 	Purac — Amended and Restated License Agreement, dated May 19, 2008
	 
	•	 	Gene Bridges — License Agreement, dated October 3, 2008

Employment Agreement

	•	 	Rudy Fogelman, dated July 26, 2006

Consultant Agreements

	•	 	Robert McFarlane, dated March 21, 2008
	 
	•	 	Arro Building Services, dated October 8, 2007
	 
	•	 	Clint Norris, dated September 1, 2008
	 
	•	 	Steve Norris (verbal agreement)

 

 

	•	 	Yi Consulting — Denny Iker, dated March 3, 2008
	 
	•	 	Safety Partners
	 
	•	 	Lonnie Ingram, dated March 11, 2005
	 
	•	 	Nexant Consulting, dated May 26, 2008
	 
	•	 	John Kane, dated November 7, 2008
	 
	•	 	Tom Solon, dated March 9, 2009
	 
	•	 	Tim Johnston, dated February 19, 2008
	 
	•	 	Mike Kelly, dated May 4, 2009
	 
	•	 	Larry Shriver, dated July 1, 2008
	 
	•	 	Shengde Zhou, dated January 16, 2009
	 
	•	 	Ron Kelly, dated June 10, 2009
	 
	•	 	CH2M Hill, dated June 2, 2009
	 
	•	 	Kelly Anderson, dated March 27, 2009
	 
	•	 	CRB Consulting, dated March 27, 2009
	 
	•	 	Hyde Engineering & Consulting, dated March 25, 2009
	 
	•	 	Fassino Design Inc., dated March 1, 2009
	 
	•	 	Richard Wright, dated January 8, 2009
	 
	•	 	Jackie Theriot, dated January 9, 2009
	 
	•	 	Spyros Svoronos, dated September 17, 2007
	 
	•	 	Dr. Wayne Genck, dated January 28, 2009
	 
	•	 	John Tomaszewicz, dated June 11, 2009

Recruiting Agreements

	•	 	J. Robert Scott, dated July 16, 2008
	 
	•	 	HireMinds, dated November 12, 2008
	 
	•	 	Groe Advisors, dated February 20, 2009
	 
	•	 	Heidrick & Struggles, dated September 14, 2007
	 
	•	 	Positions Inc.
	 
	•	 	SearchPath International, dated February 10, 2009
	 
	•	 	Venturi
	 
	•	 	BBI International
	 
	•	 	OSG Global
	 
	•	 	TowerHill Associates
	 
	•	 	Schaefer Partners, dated June 2, 2009

IT Equipment Leases & Contracts

	•	 	One Communications — Network Leased Lines (Woburn)
	 
	•	 	One Communications — Network Leased Lines (Quincy)
	 
	•	 	Comcast — Leased Network Lines for HD Video Conferencing (Quincy)
	 
	•	 	Comcast — Leased Network Lines for HD Video Conferencing (Woburn)
	 
	•	 	Conway Office Products — Konica Minolta C352 BizHub MFP (Quincy)
	 
	•	 	Conway Office Products — Konica Minolta C252 BizHub MFP (Woburn)
	 
	•	 	Conway Office Products — Xerox WorkCentre 7328 MFP (Woburn)
	 
	•	 	Verizon Wireless — 42 cellular and Blackberry phone lines

 

 

	•	 	3Com — Service Contracts for Voice-over-IP system and Network equipment
	 
	•	 	Dell — Server Hardware with Warranty
	 
	•	 	Microsoft Office — Software License
	 
	•	 	McAfee Anti-Virus — Software License
	 
	•	 	FileMaker Pro — Software License
	 
	•	 	AspenTech — License for Woburn server
	 
	•	 	OLI Systems — License for Woburn server

Letters of Credit

	•	 	Letter of Credit #68020998 from Bank of America to Cummings Properties as security deposit
for Woburn lease, dated October 2, 2007
	 
	•	 	Letter of Credit #68020999 from Bank of America to Two Batterymarch LLC as security deposit
for Quincy lease, dated October 2, 2007

Other

	•	 	Novasep — Process Design Agreement, dated June 3, 2009
	 
	•	 	Nedalco — Material Transfer Agreement, dated June 24, 2008
	 
	•	 	GEVO — Material Transfer Agreement, dated April 6, 2008
	 
	•	 	Novasep — Material Transfer Agreement, dated December 2, 2008
	 
	•	 	Ford Bacon Davis — Engineering Services Agreement, dated December 24, 2008
	 
	•	 	Nexant — PERP Report for Lactic Acid, dated June 23, 2009
	 
	•	 	Zillo Lorenzetti Group — Brazil Cellulose — Ethanol, dated August 7, 2007
	 
	•	 	UFRF — Termsheet for Pilot Plant, dated May 11, 2009
	 
	•	 	Uhde — Co-operative Agreement, dated December 4, 2008
	 
	•	 	Uhde — Material Transfer Agreement, dated June 18, 2009
	 
	•	 	Uhde — Engineering Service Agreement, dated June 24, 2009
	 
	•	 	Scientific Advisory Board Acceptance Letters of Professors Zhao, Westpheling, Dale and
Benkovic
	 
	•	 	Spectrum Engineering — Pilot Plant, dated June 29, 2007
	 
	•	 	Eurodia (Ameridia) — Pilot Process Study, dated May 20, 2009
	 
	•	 	GEA Bench Scale Lab Word, June 23, 2009
	 
	•	 	Antares — Proposal for Lake Providence Demo Plant (unsigned, dated June 15, 2009)
	 
	•	 	OLI Systems — Engine in Aspen Plus Network, dated October 22, 2008
	 
	•	 	Ameridia — Electrolysis/Bipolar Membrane Unit Lease, dated February 9, 2009
	 
	•	 	Premier Operating Co. — Anaerobic Waste Water Research Experiment Write-ups, dated March
31, 2009
	 
	•	 	Premier Operating Co. — Draft of Beneficial Use Plan for Wastewater Disposal, dated March
31, 2009
	 
	•	 	Life Cycle Associates — GREET Analysis, LCA Write-up for DOE Proposal, dated April 10,
2009
	 
	•	 	Oracle — Crystal Ball Software Suite, dated April 23, 2009
	 
	•	 	Bourne Associates — RODI System, dated May 4, 2009
	 
	•	 	AM/PM Cleaning Company — Service Contract, dated May 8, 2009
	 
	•	 	Liquid Process Solutions — Consultancy Services, dated May 18, 2009

 

 

	•	 	ENSR/AECOM — Proposal for environmental work for Lake Providence Demo Plant (unsigned,
dated June 4, 2009)
	 
	•	 	GPNA — Bench Scale Crystallization Study, dated June 19, 2009
	 
	•	 	Wisconsin Bioproducts Toll Manufacturing Agreement, dated May 18, 2009

Fixed Assets

(see attached)

 

 

Exhibit C

Excluded Assets

	•	 	Ownership interest in BioEnergy Holding LLC
	 
	•	 	Ownership interest in BioEnergy Management Services, LLC

 

 

Exhibit D

Excluded Liabilities

	•	 	$10 Million note payable to BioEnergy Holding LLC, dated August 15, 2007

 

 

EXECUTION VERSION

Exhibit E

Warrant Issuance Agreement

 

Warrant Issuance Agreement

of

Myriant Technologies LLC

Dated as of July 16, 2009

 

 

 

Warrant Issuance Agreement of

Myriant Technologies LLC

TABLE OF CONTENTS

	 	 	 	 	 

	1. DEFINITIONS
	 	 	1	 
	 
	 	 	 	 
	2. AGREEMENT TO ISSUE
	 	 	9	 
	 
	 	 	 	 
	2.1 Authorization of Securities
	 	 	9	 
	2.2 Issuance
	 	 	9	 
	 
	 	 	 	 
	3. CLOSING AND DELIVERY
	 	 	9	 
	 
	 	 	 	 
	3.1 Closing
	 	 	9	 
	3.2 Delivery
	 	 	9	 
	 
	 	 	 	 
	4. REPRESENTATIONS AND WARRANTIES OF THE COMPANY
	 	 	9	 
	 
	 	 	 	 
	4.1 Organization, Good Standing and Qualification
	 	 	9	 
	4.2 Equity Interests, Subsidiaries
	 	 	10	 
	4.3 Capitalization
	 	 	10	 
	4.4 Changes
	 	 	11	 
	4.5 Registration Rights and Voting Rights
	 	 	12	 
	4.6 Offering Valid
	 	 	12	 
	4.7 Disclosure; No Material Misstatements
	 	 	12	 
	4.8 Governmental Consents and Filings
	 	 	13	 
	4.9 Authority; Enforceability
	 	 	13	 
	4.10 Approvals; No Conflicts
	 	 	13	 
	4.11 Financial Condition; No Material Adverse Effect
	 	 	14	 
	4.12 Litigation and other Governmental Proceedings
	 	 	14	 
	4.13 Corporate Documents
	 	 	14	 
	4.14 Environmental Matters
	 	 	14	 
	4.15 Compliance with Laws and Agreements; No Defaults
	 	 	15	 
	4.16 Investment Company Act
	 	 	15	 
	4.17 Tax Matters
	 	 	15	 
	4.18 ERISA
	 	 	16	 
	4.19 Insurance
	 	 	17	 
	4.20 Location of Business and Offices
	 	 	17	 
	4.21 Properties; Title, etc
	 	 	17	 
	4.22 Maintenance of Properties
	 	 	18	 
	4.23 Swap Agreements
	 	 	18	 
	4.24 Solvency
	 	 	18	 
	4.25 Labor Matters
	 	 	18	 
	4.26 Material Contracts and Material Liabilities
	 	 	19	 
	4.27 Foreign Asset Control Regulations, etc
	 	 	19	 
	4.28 Books and Records
	 	 	19	 

-i-

 

	 	 	 	 	 

	4.29 Affiliate Transactions
	 	 	19	 
	4.30 Sufficiency of Assets
	 	 	20	 
	4.31 Consummation of the Reorganization
	 	 	20	 
	 
	 	 	 	 
	5. REPRESENTATIONS AND WARRANTIES OF THE GRANTEES
	 	 	20	 
	 
	 	 	 	 
	5.1 Formation; Requisite Power and Authority
	 	 	20	 
	5.2 Investment Representations
	 	 	20	 
	5.3 Transfer Restrictions
	 	 	22	 
	 
	 	 	 	 
	6. CONDITIONS TO CLOSING
	 	 	22	 
	 
	 	 	 	 
	6.1 Conditions to Grantees’ Obligations at the Closing
	 	 	22	 
	6.2 Conditions to Obligations of the Company
	 	 	24	 
	 
	 	 	 	 
	7. INDEMNITY
	 	 	25	 
	 
	 	 	 	 
	8. MISCELLANEOUS
	 	 	25	 
	 
	 	 	 	 
	8.1 Governing Law
	 	 	25	 
	8.2 Survival
	 	 	25	 
	8.3 Successors and Assigns
	 	 	25	 
	8.4 Entire Agreement
	 	 	25	 
	8.5 Severability
	 	 	26	 
	8.6 Amendment and Waiver
	 	 	26	 
	8.7 Delays or Omissions
	 	 	26	 
	8.8 Notices
	 	 	26	 
	8.9 Expenses
	 	 	26	 
	8.10 Attorneys’ Fees
	 	 	27	 
	8.11 Titles and Subtitles
	 	 	27	 
	8.12 Counterparts
	 	 	27	 
	8.13 Broker’s Fees
	 	 	27	 
	8.14 Exculpation Among Grantees
	 	 	27	 
	8.15 Confidentiality
	 	 	27	 
	8.16 Pronouns
	 	 	28	 

-ii-

 

Warrant Issuance Agreement

of

Myriant Technologies LLC

     This Warrant Issuance Agreement (this “Agreement”), is made
and entered into as of July 16, 2009, by and among Myriant Technologies
LLC, a Delaware limited liability company (the “Company”), and each of
those persons and entities, severally and not jointly, whose names are set forth on the Schedule of
Grantees attached hereto as Exhibit A (which persons and entities are hereinafter
collectively referred to as “Grantees” and each individually as a “Grantee”).

R E C I T A L S:

     WHEREAS, the Company has authorized the issuance of Warrants (the “Securities”)
exercisable for an aggregate of 3,750,000 units representing membership interests, all of which
will be issued pursuant to the terms and conditions of this Agreement at the Closing;

     WHEREAS, Grantees desire to be issued the Securities on the terms and conditions set forth
herein; and

     WHEREAS, the Company desires to issue the Securities to Grantees on the terms and conditions
set forth herein.

A G R E E M E N T:

     NOW, THEREFORE, in consideration of the foregoing recitals and the mutual promises,
representations, warranties, and covenants hereinafter set forth and for other good and valuable
consideration, the receipt and sufficiency of which are hereby acknowledged, the parties hereto
agree as follows:

2. DEFINITIONS.

     As used herein, the following terms shall have the following meanings, which shall be equally
applicable to both the singular and plural forms:

     “Affiliate” means, with respect to a specified Person, another Person that directly, or
indirectly through one or more intermediaries, Controls or is Controlled by or is under common
Control with the Person specified.

     “Camulos” means Camulos BioEnergy Partners LLC, a Delaware limited liability company.

     “Capital Leases” means, in respect of any Person, all leases which shall have been, or should
have been, in accordance with GAAP, recorded as capital leases on the balance sheet of the Person
liable (whether contingent or otherwise) for the payment of rent thereunder.

     “Closing” has the meaning assigned such term in Section 3.1.

1

 

     “Closing Date” has the meaning assigned such term in Section 3.1.

     “Code” means the Internal Revenue Code of 1986, as amended from time to time, and any
successor statute.

     “Company Group” means the Company and its Subsidiaries.

     “Company Parties” has the meaning assigned such term in Section 7.

     “Consolidated Subsidiaries” means each Subsidiary of the Company (whether now existing or
hereafter created or acquired) the financial statements of which shall be (or should have been)
consolidated with the financial statements of the Company in accordance with GAAP.

     “Contribution Agreement” means that certain Contribution and Exchange Agreement, dated as of
even date herewith, by and among the Company and each of the Holders (as defined therein).

     “Control” means the possession, directly or indirectly, of the power to direct or cause the
direction of the management or policies of a Person, whether through the ownership of voting
securities, by contract or otherwise. For the purposes of this definition, and without limiting
the generality of the foregoing, any Person that owns directly or indirectly 10% or more of the
Equity Interests having ordinary voting power for the election of the directors or other governing
body of a Person (other than as a limited partner of such other Person) will be deemed to “control”
such other Person. “Controlling” and “Controlled” have meanings correlative thereto.

     “Conversion Securities” has the meaning assigned such term in Section 2.1.

     “Convertible Securities” means any options, rights, warrants or other securities exercisable
or exchangeable for or convertible into Units.

     “Damages” has the meaning assigned such term in Section 7.

     “Debt” means, for any Person, the sum of the following (without duplication): (a) all
obligations of such Person for borrowed money or evidenced by bonds, bankers’ acceptances,
debentures, notes or other similar instruments; (b) all obligations of such Person (whether
contingent or otherwise) in respect of letters of credit, surety or other bonds and similar
instruments; (c) all accounts payable and all accrued expenses, liabilities or other obligations of
such Person to pay the deferred purchase price of Property or services; (d) all obligations under
Capital Leases; (e) all obligations under Synthetic Leases; (f) all Debt (as defined in the other
clauses of this definition) of others secured by (or for which the holder of such Debt has an
existing right, contingent or otherwise, to be secured by) a Lien on any Property of such Person,
whether or not such Debt is assumed by such Person; (g) all Debt (as defined in the other clauses
of this definition) of others guaranteed by such Person or in which such Person otherwise assures a
creditor against loss of the Debt (howsoever such assurance shall be made) to the extent of the
lesser of the amount of such Debt and the maximum stated amount of such guarantee or assurance
against loss; (h) all obligations or undertakings of such Person to maintain or cause to be
maintained the financial position or covenants of others or to purchase the Debt or Property of

2

 

others; (i) obligations to deliver commodities, goods or services in consideration of one or
more advance payments; (j) obligations to pay for goods or services even if such goods or services
are not actually received or utilized by such Person; (k) any Debt (as defined in other clauses of
this definition) of a partnership for which such Person is liable either by agreement, by operation
of law or by a Governmental Requirement but only to the extent of such liability; (l) the
undischarged balance of any production payment created by such Person or for the creation of which
such Person directly or indirectly received payment; and (m) any purchase money security interest
in any property, or interest therein created or assumed contemporaneously with the purchase of such
property, or interest therein, to secure or provide for the payment or financing of any part of the
purchase price thereof. The Debt of any Person shall include all obligations of such Person of the
character described above to the extent such Person remains legally liable in respect thereof
notwithstanding that any such obligation is not included as a liability of such Person under GAAP.

     “Environmental Claim” means any claim, demand, proceeding, suit, investigation, loss, cost,
expense, liability, penalty or damage arising, incurred or otherwise asserted pursuant to any
Environmental Law.

     “Environmental Law” means any and all Governmental Requirements pertaining to pollution,
protection of human health or the environment, or workplace health and safety, including without
limitation the Comprehensive Environmental Response, Compensation and Liability Act, 42 U.S.C. §
9601 et seq.; the Resource Conservation and Recovery Act, 42 U.S.C. § 6901 et seq.; the Federal
Water Pollution Control Act, 33 U.S.C. § 1251 et seq.; the Clean Air Act, 42 U.S.C. § 7401 et seq.;
the Hazardous Materials Transportation Act, 49 U.S.C. § 1471 et seq.; the Toxic Substances Control
Act, 15 U.S.C. §§ 2601 et seq.; the Oil Pollution Act, 33 U.S.C. § 2701 et seq.; the Emergency
Planning and Community Right-to-Know Act, 42 U.S.C. § 11001 et seq.; the Safe Drinking Water Act,
42 U.S.C. §§ 300f through 300j-26; the Occupational Safety and Health Act, 29 U.S.C. § 651 et seq.;
and all similar Governmental Requirements of any Governmental Authority having jurisdiction over
the Company or its Properties or operations, and all amendments to such Governmental Requirements
and all regulations implementing any of the foregoing.

     “Equity Interests” means shares of capital stock, partnership interests, membership interests
in a limited liability company, beneficial interests in a trust or other equity ownership interests
in a Person, and any warrants, options or other rights entitling the holder thereof to purchase or
acquire any such Equity Interest.

     “ERISA” means the Employee Retirement Income Security Act of 1974, as amended, and any
successor statute.

     “ERISA Affiliate” means each trade or business (whether or not incorporated) which together
with the Company or its Subsidiaries would be deemed to be a “single employer” within the meaning
of section 4001(b)(1) of ERISA or subsections (b), (c), (m) or (o) of section 414 of the Code.

     “ERISA Event” means (a) a “Reportable Event” described in section 4043 of ERISA and the
regulations issued thereunder, (b) the withdrawal of the Company, any of its Subsidiaries or

3

 

any ERISA Affiliate from a Plan during a plan year in which it was a “substantial employer” as
defined in section 4001(a)(2) of ERISA, (c) the filing of a notice of intent to terminate a Plan or
the treatment of a Plan amendment as a termination under section 4041 of ERISA, (d) the institution
of proceedings to terminate a Plan by the PBGC, (e) receipt of a notice of withdrawal liability
pursuant to Section 4202 of ERISA or (f) any other event or condition which might constitute
grounds under section 4042 of ERISA for the termination of, or the appointment of a trustee to
administer, any Plan.

     “Exchange Agreement” means that certain Exchange Agreement dated as of even date herewith, by
and among the Company, Camulos, Itera, NGPC and Plainfield Finance.

     “Fully Diluted Outstanding” means, at any date when the number of units is to be determined,
all Units outstanding at such date, and all units issuable pursuant to all options or other
Convertible Securities outstanding on such date.

     “GAAP” means generally accepted accounting principles in the United States of America as in
effect from time to time.

     “Governmental Authority” means the government of the United States of America, any other
nation or any political subdivision thereof, whether state or local, and any agency, authority,
instrumentality, regulatory body, court, central bank or other entity exercising executive,
legislative, judicial, taxing, regulatory or administrative powers or functions of or pertaining to
government over any member of the Company Group or any Grantee.

     “Governmental Requirement” means any law, statute, code, ordinance, order, determination,
rule, regulation, judgment, decree, injunction, franchise, permit, certificate, license,
authorization or other directive or requirement, whether now or hereinafter in effect, including,
without limitation, Environmental Laws, energy regulations and occupational, safety and health
standards or controls, of any Governmental Authority.

     “Grantee” and “Grantees” has the meaning assigned to such term in the preamble.

     “Grantee Parties” has the meaning assigned such term in Section 7.

     “Hazardous Material” means and includes each substance defined, designated or classified as a
hazardous waste, hazardous substance, hazardous material, pollutant, contaminant or toxic substance
under any Environmental Law and any petroleum or petroleum products that have been Released into
the environment.

     “Insider” means any officer, director, member, or Affiliate, as applicable, of the Company or
any of its Affiliates or any immediate family member of such Person (including, without limitation,
any Person related by marriage or adoption to any such individual) or any entity in which any such
Person owns a ten percent (10%) or greater beneficial interest.

     “International” means BioEnergy International, LLC, a Delaware limited liability company.

4

 

     “International Assignments” means, collectively, (i) that certain Assignment dated as of even
date herewith, by Itera in favor of the Company, pursuant to which Itera assigns to the Company,
its right to purchase up to 243,798 of the International Units under that certain Warrant dated as
of even date herewith, between Itera and International, (ii) that certain Assignment dated as of
even date herewith, by Plainfield Finance in favor of the Company, pursuant to which Plainfield
Finance assigns to the Company its right to purchase up to 2,114,355 of the International Units
under that certain Warrant dated as of even date herewith, between Plainfield Finance and
International, (iii) that certain Assignment dated as of even date herewith, by NGPC in favor of
the Company, pursuant to which NGPC assigns to the Company, its right to purchase up to 507,313 of
the International Units under that certain Warrant dated as of even date herewith, between NGPC and
International, (iv) that certain Assignment dated as of even date herewith, by Camulos in favor of
the Company, pursuant to which Camulos assigns to the Company, its right to purchase up to 884,534
of the International Units under that certain Warrant dated as of even date herewith, between
Camulos and International, and (v) that certain Assignment dated as of even date herewith, by
Plainfield Finance in favor of the Company, pursuant to which Plainfield Finance assigns to the
Company, its right to purchase up to 423,077 of the International Units under that certain Warrant
dated as of even date herewith, between Plainfield Finance and International.

     “International Units” means units representing membership interests of International.

     “International Warrants” means, collectively, (i) that certain Warrant dated as of even date
herewith, between Camulos and International, entitling Camulos to purchase up to 245,336
International Units as provided therein, (ii) that certain Warrant dated as of even date herewith,
between NGPC and International, entitling NGPC to purchase up to 140,687 International Units as
provided therein, (iii) that certain Warrant dated as of even date herewith, between Itera and
International, entitling Itera to purchase up to 76,981 International Units as provided therein,
and (iv) that certain Warrant dated as of even date herewith, between Plainfield Finance and
International, entitling Plainfield Finance to purchase up to 636,996 International Units as
provided therein.

     “Itera” means Itera Ethanol, LLC, a Delaware limited liability company.

     “Lien” means any interest in Property securing an obligation owed to, or a claim by, a Person
other than the owner of the Property, whether such interest is based on the common law, statute or
contract, and whether such obligation or claim is fixed or contingent, and including but not
limited to the lien or security interest arising from a mortgage, encumbrance, pledge, security
agreement, conditional sale or trust receipt or a lease, consignment or bailment for security
purposes and any purchase money security interest in any property, or interest therein created or
assumed contemporaneously with the purchase of such property, or interest therein, to secure or
provide for the payment or financing of any part of the purchase price thereof. The term “Lien”
shall include easements, restrictions, servitudes, permits, conditions, covenants, exceptions or
reservations. For the purposes of this Agreement, the Company and the Subsidiaries shall be deemed
to be the owner of any Property which they have acquired or hold subject to a conditional sale
agreement, or leases under a financing lease or other arrangement pursuant to which title to the
Property has been retained by or vested in some other Person in a transaction intended to create a
financing.

5

 

     “LLC Agreement” has the meaning assigned such term in Section 2.1.

     “Material Adverse Effect” means a material adverse change in, or material adverse effect on
(a) the business, operations, Property, liabilities, (actual or contingent) condition (financial or
otherwise) or prospects of the Company Group taken as a whole, (b) the ability of the Company Group
to perform any of its obligations under any Transaction Document to which it is a party, (c) the
validity or enforceability of any Transaction Document or (d) the rights and remedies of or
benefits available to any Grantee under any Transaction Document.

     “Material Indebtedness” means Debt or obligations in respect of one or more Swap Agreements,
of the Company and each of its Subsidiaries in an aggregate principal amount exceeding $1,000,000.
For purposes of determining Material Indebtedness, the “principal amount” of the obligations of the
Company or any of its Subsidiaries in respect of any Swap Agreement at any time shall be the Swap
Termination Value.

     “Multiemployer Plan” means a Plan which is a multiemployer plan as defined in section 3(37) or
4001 (a)(3) of ERISA.

     “Myriant Assignments” means, collectively, (i) that certain Assignment dated as of even date
herewith, by NGPC in favor of Plainfield Finance, pursuant to which NGPC assigns to Plainfield
Finance its right to purchase up to 113,651 of the Units under that certain Warrant dated as of
even date herewith, between NGPC and the Company, (ii) that certain Assignment dated as of even
date herewith, by NGPC in favor of Itera, pursuant to which NGPC assigns to Itera its right to
purchase up to 24,948 of the Units under that certain Warrant dated as of even date herewith,
between NGPC and the Company, (iii) that certain Assignment dated as of even date herewith, by
Camulos in favor of Plainfield Finance, pursuant to which Camulos assigns to Plainfield Finance its
right to purchase up to 198,189 of the Units under that certain Warrant dated as of even date
herewith, between Camulos and the Company, and (iv) that certain Assignment dated as of even date
herewith, by Camulos in favor of Itera, pursuant to which Camulos assigns to Itera its right to
purchase up to 43,505 of the Units under that certain Warrant dated as of even date herewith,
between Camulos and the Company.

     “NGPC” means NGP Capital Resources Company, a Maryland corporation.

     “Paying Party” has the meaning assigned such term in Section 8.13.

     “PBGC” means the Pension Benefit Guaranty Corporation, or any successor thereto.

     “Permit” means any permit, license, authorization, registration or similar form or approval or
permission required by any Governmental Authority or pursuant to any Governmental Requirement.

     “Person” means any natural person, corporation, limited liability company, trust, joint
venture, association, company, partnership, Governmental Authority or other entity.

     “Plainfield Finance” means Plainfield Finance Corporation, a Delaware corporation.

6

 

     “Plan” means any employee pension benefit plan, as defined in section 3(2) of ERISA, which (a)
is currently or hereafter sponsored, maintained or contributed to by the Company, a Subsidiary or
an ERISA Affiliate or (b) was at any time during the six calendar years preceding the date hereof,
sponsored, maintained or contributed to by the Company, or a Subsidiary or an ERISA Affiliate.

     “Property” means any interest in any kind of property or asset, whether real, personal or
mixed, or tangible or intangible, including, without limitation, cash, securities, accounts and
contract rights.

     “Redemption” means with respect to any Debt, the repurchase, redemption, prepayment,
repayment, or defeasance or any other acquisition or retirement for value (or the segregation of
funds with respect to any of the foregoing) of such Debt. “Redeem” has the correlative meaning
thereto.

     “Registration Rights Agreement” has the meaning assigned such term in Section 4.1.

     “Release” means any depositing, spilling, leaking, pumping, pouring, placing, emitting,
discarding, abandoning, emptying, discharging, migrating, injecting, escaping, leaching, dumping,
or disposing.

     “Relevant Party” has the meaning assigned such term in Section 8.15.

     “Reorganization” means that certain corporate reorganization set forth in that certain
BioEnergy Group Reorganization Authority Steps Memo, dated as of even date herewith, and attached
hereto as Exhibit E, pursuant to which International will distribute its specialty chemical
assets to the Company.

     “Securities” has the meaning assigned such term in the recitals to this Agreement.

     “Securities Act” has the meaning assigned such term in Section 4.6.

     “Subsidiary” means (a) any Person of which at least a majority of the outstanding Equity
Interests having by the terms thereof ordinary voting power to elect a majority of the board of
directors, manager or other governing body of such Person (irrespective of whether or not at the
time Equity Interests of any other class or classes of such Person shall have or might have voting
power by reason of the happening of any contingency) is at the time directly or indirectly owned or
controlled by the Company or one or more of the Subsidiaries of the Company, and (b) any
partnership of which the Company or any of its Subsidiaries is a general partner. Unless otherwise
indicated herein, each reference to the term “Subsidiary” shall mean a Subsidiary of the Company.

     “Swap Agreement” means any agreement with respect to any swap, forward, future or derivative
transaction or option or similar agreement, whether exchange traded, “over-the-counter” or
otherwise, involving, or settled by reference to, one or more rates, currencies, commodities,
equity or debt instruments or securities, or economic, financial or pricing indices or measures of
economic, financial or pricing risk or value or any similar transaction or any combination of these
transactions; provided that no phantom unit or similar plan providing for

7

 

payments only on account of services provided by current or former directors, officers,
employees or consultants of the Company or the Subsidiaries shall be a Swap Agreement.

     “Swap Termination Value” means, in respect of any one or more Swap Agreements, after taking
into account the effect of any legally enforceable netting agreement relating to such Swap
Agreements, (a) for any date on or after the date such Swap Agreements have been closed out and
termination value(s) determined in accordance therewith, such termination value(s) and (b) for any
date prior to the date referenced in clause (a), the amount(s) determined as the mark-to-market
value(s) for such Swap Agreements, as determined by the counterparties to such Swap Agreements.

     “Synthetic Leases” means, in respect of any Person, all leases which shall have been, or
should have been, in accordance with GAAP, treated as operating leases on the financial statements
of the Person liable (whether contingently or otherwise) for the payment of rent thereunder and
which were properly treated as indebtedness for borrowed money for purposes of U.S. federal income
taxes, if the lessee in respect thereof is obligated to either purchase for an amount in excess of,
or pay upon early termination an amount in excess of, 80% of the residual value of the Property
subject to such operating lease upon expiration or early termination of such lease.

     “Taxes” means any and all present or future taxes, levies, imposts, duties, deductions,
assessments, fees or other charges or withholdings imposed by any Governmental Authority, including
any interest, additions to tax or penalties applicable thereto.

     “Transaction Documents” means this Agreement, the Contribution Agreement, the Exchange
Agreement, the International Assignments, the International Warrants, the LLC Agreement, the
Myriant Assignments, the Registration Rights Agreement, the Transfer Agreement, the Warrant
Cancellation Agreements, and the Warrants and all other agreements, instruments, consents or
certificates now or hereafter executed and delivered by the Company or any other Person in
connection with the Reorganization, as such agreements may be amended, modified, supplemented or
restated from time to time.

     “Transactions” means, with respect to the Company, the execution, delivery and performance by
the Company of this Agreement and each other Transaction Document to which it is a party.

     “Transfer Agreement” means that certain Transfer, Assignment and Assumption Agreement dated as
of even date herewith, by and between International and the Company.

     “Transferred Assets” has the meaning assigned such term in the Transfer Agreement.

     “Units” means the units representing membership interests in the Company.

     “Warrant Cancellation Agreements” means, collectively, (i) that certain Warrant Cancellation
Agreement dated as of even date herewith, by and between the Company and International, cancelling
warrants exercisable for 3,750,000 International Units, (ii) that certain Warrant Cancellation
Agreement dated as of even date herewith, by and between the Company and International, cancelling
warrants exercisable for 423,077 International Units and (iii) that

8

 

certain Warrant Cancellation Agreement dated as of even date herewith, by and among the
Company, Plainfield Finance, Itera, NGPC and Camulos, cancelling warrants exercisable for 1,933,333
Units.

     “Warrants” means those certain Warrants dated as of the date hereof, issued by Company to each
Grantee for the purchase of Units in the Company and all warrants issued upon transfer, division or
combination of, or in substitution for, any thereof; provided that all Warrants shall at all times
be identical as to terms and conditions and date, except as to the number of Units for which they
may be exercised.

3. AGREEMENT TO ISSUE.

     3.1 Authorization of Securities. On or prior to the Closing (as defined in Section 3
below), the Company shall have authorized (a) the issuance to Grantees of the Securities and (b)
the issuance of such Units to be issued upon exercise of the Securities (the “Conversion
Securities”). The Conversion Securities shall have the rights, preferences, privileges and
restrictions set forth in that certain Limited Liability Company Operating Agreement of the
Company, in the form attached hereto as Exhibit B (the “LLC Agreement”).

     3.2 Issuance. Subject to the terms and conditions hereof, at the Closing (as
hereinafter defined) the Company hereby agrees to issue to each Grantee, severally and not jointly,
and each Grantee agrees to be granted by the Company, severally and not jointly, the Securities
exercisable for the number of Units set forth opposite such Grantee’s name on Exhibit A set
forth in the column labeled “Number of Warrants”, for Ten Dollars ($10.00), in the aggregate, and
other good and valuable consideration, the receipt and sufficiency of which is hereby acknowledged.

4. CLOSING AND DELIVERY.

     4.1 Closing. The closing of the issuance of the Securities set forth on Exhibit
A in the column labeled “Number of Warrants” under this Agreement (the “Closing”) shall
take place at 10:00 a.m. on the date hereof, at the offices of the Company or at such other time or
place as the Company and Grantees may mutually agree (such date is hereinafter referred to as the
“Closing Date”), and the Closing will occur with respect to all of the Grantees
simultaneously.

     4.2 Delivery. At the Closing, subject to the terms and conditions hereof, the Company
will deliver to each Grantee a Security exercisable for the number of Units specified in
Exhibit A.

5. REPRESENTATIONS AND WARRANTIES OF THE COMPANY.

     Except as set forth on a Schedule of Exceptions delivered by the Company to the Grantees at
the Closing, the Company hereby represents and warrants to each Grantee as of the date of this
Agreement and as of the consummation of all the Transactions the following:

     5.1 Organization, Good Standing and Qualification. The Company is a limited liability
company duly organized, validly existing and in good standing under the laws of the State of
Delaware. The Company has all requisite power and authority, and has all material

9

 

governmental and third-party licenses, authorizations, consents and approvals necessary, to
own and operate its properties and assets, to execute and deliver this Agreement, the Registration
Rights Agreement in the form attached hereto as Exhibit C (the “Registration Rights
Agreement”) and the Securities in the form attached hereto as Exhibit D, to issue and
sell the Securities and the Conversion Securities, and to carry out the provisions of this
Agreement, the Registration Rights Agreement, the Securities and the LLC Agreement and to carry on
its business as presently conducted. The Company is duly qualified and is authorized to do
business and is in good standing as a foreign limited liability company in all jurisdictions in
which the nature of its activities and of its properties (both owned and leased) makes such
qualification necessary, except for those jurisdictions where the failure to have such power,
authority, licenses, authorizations, consents, approvals and qualifications would not have a
Material Adverse Effect.

     5.2 Equity Interests, Subsidiaries. Set forth on Schedule 4.2, is a complete
and accurate description of the authorized Equity Interests of the Company and each of its
Subsidiaries, by class, and, as of the Closing Date, a description of the number of shares,
interests, units or other Equity Interests of each such class that are issued and outstanding and
the record owner or holder thereof. Other than as described on Schedule 4.2, there are no
subscriptions, options, warrants, or calls granted by the Company or any of its Subsidiaries (or
approved by the governing body of the Company or any of its Subsidiaries but not yet granted, and
pursuant to any such approval where such governing body retains total control as to such granting)
relating to any of the Company’s or its Subsidiaries’ Equity Interests, including any right of
conversion or exchange under any outstanding security or other instrument. Except as otherwise set
forth on Schedule 4.2, neither the Company nor any of its Subsidiaries is subject to any
obligation (contingent or otherwise) to repurchase or otherwise acquire or retire any of its Equity
Interests or any security convertible into or exchangeable for any of its Equity Interests. All of
the outstanding Equity Interests of the Company and each of its Subsidiaries have been validly
issued and are (in the case of corporate securities) fully paid and non-assessable. As of the
Closing Date, the Company has no Subsidiaries other than those set forth on Schedule 4.2.

     5.3 Capitalization. The rights, preferences, privileges and restrictions of the
Conversion Securities are as stated in the LLC Agreement. The Securities are exercisable for Units
of the Company, representing in the aggregate 3,750,000 of the Company’s Fully Diluted Outstanding
Units. The Conversion Securities have been duly and validly reserved for issuance. When issued,
sold and delivered in compliance with the provisions of this Agreement and the LLC Agreement, the
Securities and the Conversion Securities will be duly authorized, validly issued, and will be free
of any liens or encumbrances other than liens and encumbrances created by or imposed upon the
Grantees; provided, however, that the Securities and the Conversion Securities may be subject to
restrictions agreed to under the LLC Agreement, including certain rights of first refusal and
restrictions on transfer under state and/or federal securities laws as set forth herein or as
otherwise required by such laws at the time a transfer is proposed. The Units issued pursuant to
the Contribution Agreement will be duly authorized, validly issued, and will be free of any liens
or encumbrances other than liens and encumbrances created by or imposed upon the Holders (as
defined therein); provided, however, that such Units may be subject to restrictions agreed to under
the LLC Agreement, including certain rights of first refusal and restrictions on transfer under
state and/or federal securities laws as set forth herein or as otherwise required by such laws at
the time a transfer is proposed. The Units issued pursuant to

10

 

the Exchange Agreement will be duly authorized, validly issued, and will be free of any liens
or encumbrances other than liens and encumbrances created by or imposed upon the Grantees;
provided, however, that such Units may be subject to restrictions agreed to under the LLC
Agreement, including certain rights of first refusal and restrictions on transfer under state
and/or federal securities laws as set forth herein or as otherwise required by such laws at the
time a transfer is proposed

     5.4 Changes. Since April 3, 2009, and except as set forth in Schedule 4.4 of
the Schedule of Exceptions, there has not been:

          (a) Any material change in the assets, liabilities, financial condition, or operations of any
member of the Company Group from that reflected in the financial statements, other than changes in
the ordinary course of business consistent with past practice;

          (b) Any material change, except in the ordinary course of business, in the contingent
obligations of any member of the Company Group by way of guaranty, endorsement, indemnity, warranty
or otherwise;

          (c) Any damage, destruction or loss, whether or not covered by insurance, materially and
adversely affecting the properties, business or financial condition of any member of the Company
Group;

          (d) Any waiver by any member of the Company Group of a valuable right or of a material debt
owed to it;

          (e) Any direct or indirect loans made by any member of the Company Group to any of its
members, employees, officers or directors, other than advances made in the ordinary course of
business consistent with past practice;

          (f) Except in the ordinary course of business consistent with past practice, any material
change in any compensation arrangement or agreement with any employee, officer, director or member
of any member of the Company Group;

          (g) Any declaration or payment of any dividend or other distribution of the assets of any
member of the Company Group;

          (h) Any labor organization activity related to any member of the Company Group;

          (i) Any Debt, obligation or liability incurred, assumed or guaranteed by any member of the
Company Group, except those for immaterial amounts and for current liabilities incurred in the
ordinary course of business consistent with past practice;

          (j) Any sale, assignment or transfer of any patents, trademarks, copyrights, trade secrets or
other intangible assets of any member of the Company Group;

11

 

          (k) Any change in any material agreement to which any member of the Company Group is a party
or by which it is bound which materially affects the business, assets, liabilities, financial
condition or operations of any member of the Company Group;

          (l) Any mortgage, pledge, transfer of a security interest in, or lien, created by any member
of the Company Group with respect to any of its material properties or assets, except liens for
taxes not yet due or payable and liens that arise in the ordinary course of business consistent
with past practice and do not materially impair any member of the Company Group’s ownership or use
of such properties or assets.

          (m) Any arrangement or commitment by any member of the Company Group to do any of the acts
described in subsection (a) through (l) above.

     5.5 Registration Rights and Voting Rights. Except as required pursuant to the
Registration Rights Agreement, no member of the Company Group is presently under any obligation, or
has granted any rights, to register any of its presently outstanding securities or any of its
securities that may hereafter be issued. Except as required pursuant to the LLC Agreement no
equity holder of any member of the Company Group has entered into any agreement with respect to the
voting of equity securities of such member of the Company Group.

     5.6 Offering Valid. Assuming the accuracy of the representations and warranties of
the Grantees contained in Section 5.2 hereof, the offer, sale and issuance of the Securities, the
Conversion Securities and the issuance of the Units pursuant to the Contribution Agreement and the
Exchange Agreement will be exempt from the registration requirements of the Securities Act of 1933,
as amended (the “Securities Act”), and will have been registered or qualified (or are
exempt from registration and qualification) under the registration, permit or qualification
requirements of all applicable state securities laws. Neither the Company nor any agent on its
behalf has solicited or will solicit any offers to sell or has offered to sell or will offer to
sell all or any part of the Securities to any person or persons so as to bring the sale of such
Securities by the Company within the registration provisions of the Securities Act or any state
securities laws. No Person is entitled to preemptive rights under any contract or applicable law
in connection with the issuance of the Securities.

     5.7 Disclosure; No Material Misstatements. The Company and each of its Subsidiaries
has disclosed to each Grantee all agreements, instruments and corporate or other restrictions to
which it is subject, and all other matters to the Company’s knowledge which affect its assets,
financial condition, Properties or current operations that, individually or in the aggregate,
would, or would reasonably be expected to have, a Material Adverse Effect. None of the reports,
financial statements, certificates or other information furnished by or on behalf of the Company or
any Subsidiary to any Grantee or any of their Affiliates in connection with the negotiation of this
Agreement or any other Transaction Document or delivered hereunder or thereunder (as modified or
supplemented by other information so furnished) taken as a whole contains any material misstatement
of fact or omits to state any material fact necessary to make the statements therein, in the light
of the circumstances under which they were made, not misleading; provided that, with respect to
projected financial information, the Company and each of its Subsidiaries represent only that such
information was prepared in good faith based upon assumptions believed to be reasonable at the
time.

12

 

     5.8 Governmental Consents and Filings. Assuming the accuracy of the representations
made by the Grantees in Section 5 of this Agreement, no consent, approval, order or authorization
of, or registration, qualification, designation, declaration or filing with, any Governmental
Authority or other third party is required on the part of the Company in connection with the
consummation of the transactions contemplated by the Transaction Documents, except for (i) filings
pursuant to Regulation D of the Securities Act, and applicable state securities laws, which have
been made or will be made in a timely manner, and (ii) with respect to the Registration Rights
Agreement, the registration of units contemplated thereby with the Securities and Exchange
Commission.

     5.9 Authority; Enforceability. The Transactions are within each member of the Company
Group ’s limited liability company, corporate or partnership powers (as the case may be) and have
been duly authorized by all necessary limited liability company, corporate or partnership (as the
case may be) action and, if required, member, partner, director or stockholder action (including,
without limitation, any action required to be taken by any class of members, partners, directors or
stockholders of any member of the Company Group or any other Person, whether interested or
disinterested, in order to ensure the due authorization of the Transactions). Each Transaction
Document to which any member of the Company Group is a party has been duly executed and delivered
by such member of the Company Group and constitutes a legal, valid and binding obligation of such
member of the Company Group, as applicable, enforceable in accordance with its terms, subject to
applicable bankruptcy, insolvency, reorganization, moratorium or other laws affecting creditors’
rights generally and subject to general principles of equity, regardless of whether considered in a
proceeding in equity or at law.

     5.10 Approvals; No Conflicts. Except as set forth on Schedule 4.10, the
Transactions (a) do not require any consent or approval of, registration or filing with, or any
other action by, any Governmental Authority or any other third Person (including members, partners,
directors or stockholders, whether interested or disinterested, of the Company or any other
Person), nor is any such consent, approval, registration, filing or other action necessary for the
validity or enforceability of any Transaction Document or the consummation of the transactions
contemplated thereby, except (i) such as have been obtained or made and are in full force and
effect or, in the reasonable judgment of the Company Group, can reasonably be expected to be
obtained if so required, and (ii) those third party approvals or consents which, if not made or
obtained, would not reasonably be expected to have a Material Adverse Effect or do not have a
Material Adverse Effect on the enforceability of the Transaction Documents, (b) will not violate
any applicable law or regulation or the charter, by-laws or other organizational documents of any
member of the Company Group or any order of any Governmental Authority, and (c) do not constitute
with or without notice or the passage of time or both, a material violation, breach or default,
create or impose a Lien upon any Property of the Company, or give rise to any right of termination,
modification, cancellation, or prepayment, under (i) any applicable law or regulation or the
charter, by-laws or other organizational documents of the Company Group or any order of any
Governmental Authority, or (ii) any indenture, agreement or other instrument binding upon the
Company or its Properties, or give rise to a right thereunder to require any payment to be made by
the Company except those violations, breaches, defaults, Liens upon the Property of the Company,
terminations, modifications, cancellations, and prepayments which would not reasonably be expected
to have a Material Adverse Effect or do not have a Material Adverse Effect on the Company, its
business, assets or Properties.

13

 

     5.11 Financial Condition; No Material Adverse Effect.

          (a) Since April 3, 2009, (i) there has been no event, development or circumstance that has had
or would reasonably be expected to have a Material Adverse Effect and (ii) the business of the
Company and each of its Subsidiaries has been conducted only in the ordinary course consistent with
past business practices.

          (b) The Company does not have on the date hereof any material Debt or any contingent
liabilities, off-balance sheet liabilities or partnerships, liabilities for Taxes, unusual forward
or long-term commitments or unrealized or anticipated losses from any unfavorable commitments,
except as (i) disclosed on Schedule 4.11.

     5.12 Litigation and other Governmental Proceedings. Except as set forth on
Schedule 4.12, there are no actions, suits, investigations or proceedings by or before any
arbitrator or Governmental Authority pending against or, to the knowledge of the Company,
threatened against or affecting the Company or any Subsidiary (i) as to which there is a reasonable
possibility of an adverse determination that would reasonably be expected, individually or in the
aggregate, to result in a Material Adverse Effect, or (ii) that involve any Transaction Document or
the Transactions.

     5.13 Corporate Documents. The copies of the constitutive documents of the Company and
each of its Subsidiaries, including, without limitation, the LLC Agreement, (where applicable,
certified by the Secretary of State of the state of its incorporation or formation as of a date
within thirty days of the date of this agreement) have been made available to the Grantees and are
true, complete and correct.

     5.14 Environmental Matters. Except for matters that, individually or in the
aggregate, could not reasonably be expected to have a Material Adverse Effect:

          (a) The Company and each of its Subsidiaries and their respective Properties and operations
are and, during the periods specified in all applicable statutes of limitation, have been in
compliance with applicable Environmental Laws;

          (b) The Company and each of its Subsidiaries timely applied for, possess, and are in
compliance with, all Permits required under applicable Environmental Laws for their operations as
presently conducted and such Permits are in the name of the proper entity and will remain in full
force and effect following the Closing;

          (c) The Company and each of its Subsidiaries and their respective Properties and operations
are not subject to any pending or, to the knowledge of the Company, threatened Environmental
Claims, nor has the Company or any of its Subsidiaries received any written notice of Environmental
Claims;

          (d) There has been no Release of Hazardous Materials on, in, under or from the Properties by
the Company or any of its Subsidiaries or from or in connection with the operations of the Company
or any of its Subsidiaries that (i) is in violation of any applicable Environmental Laws; or (ii)
is Released or threatened to be Released in a manner that could give rise to any remedial or
corrective action obligations pursuant to Environmental Laws; and

14

 

          (e) There has been no exposure of any Person or property in connection with the operations of
the Company or any of its Subsidiaries that could reasonably be expected to form the basis for an
Environmental Claim or any other claim for damages or compensation.

          (f) EXCEPT AS PROVIDED IN THIS SECTION 4.13, THE COMPANY AND EACH OF ITS SUBSIDIARIES MAKE NO
REPRESENTATION OR WARRANTY, EXPRESS OR IMPLIED, WITH RESPECT TO ENVIRONMENTAL MATTERS.

     5.15 Compliance with Laws and Agreements; No Defaults.

          (a) The Company and each of its Subsidiaries are in compliance with all Governmental
Requirements applicable to them or their Properties, businesses, operations, employees, assets and
all agreements and other instruments binding upon them or their Properties, and possess all
licenses, permits, franchises, exemptions, approvals and other governmental authorizations
necessary for the ownership of their respective Properties and the conduct of their respective
businesses, except where the failure to do so, individually or in the aggregate, would not
reasonably be expected to result in a Material Adverse Effect.

          (b) The Company and each of its Subsidiaries are not in default nor has any event or
circumstance occurred which, but for the expiration of any applicable grace period or the giving of
notice, or both, would constitute a default or would require the Company or any of its Subsidiaries
to Redeem or make any offer to Redeem under any indenture, note, credit agreement or instrument
pursuant to which any Material Indebtedness is outstanding or by which the Company or any of its
Subsidiaries or any of its Properties is bound.

     5.16 Investment Company Act. The Company is not an “investment company” or a company
“controlled” by an “investment company,” within the meaning of, or subject to regulation under, the
Investment Company Act of 1940, as amended.

     5.17 Tax Matters. The Company and each of its Subsidiaries have timely filed or
caused to be filed all Tax returns, reports, certifications and disclosures required to have been
filed and all such filings are true, correct and complete in all respects and have paid or caused
to be paid all Taxes required to have been paid by them, except (a) Taxes that are being contested
in good faith by appropriate proceedings and for which the Company and each of its Subsidiaries
have set aside on their books adequate reserves in accordance with GAAP or (b) to the extent that
the failure to do so would not reasonably be expected to result in a Material Adverse Effect.
Except to the extent that the failure to do so would not reasonably be expected to have a
Material Adverse Effect all Tax withholding and deposit requirements imposed on or with respect
to the Company and each of its Subsidiaries have been satisfied in full in all respects. All other
charges, accruals and reserves on the books of the Company and its Subsidiaries have in respect of
Taxes and other governmental charges are, in the reasonable opinion of the Company,
adequate. No Tax Lien has been filed and, to the knowledge of the Company, no claim is
being asserted with respect to any such Tax or other such governmental charge. No claim has been
made against the Company or any of its Subsidiaries by a tax authority in a jurisdiction where the
Company or such Subsidiary does not file tax returns that the Company or such Subsidiary is or may
be subject to taxes in such jurisdiction.

15

 

     5.18 ERISA.

          (a) Except as could not be reasonably be expected to result in a Material Adverse Effect, the
Company and each of its Subsidiaries have and each ERISA Affiliate have complied in all material
respects with ERISA and, where applicable, the Code regarding each Plan.

          (b) Except as could not be reasonably be expected to result in a Material Adverse Effect, each
Plan is, and has been, maintained in substantial compliance with ERISA and, where applicable, the
Code.

          (c) Except as could not be reasonably be expected to result in a Material Adverse Effect, no
act, omission or transaction has occurred which could result in imposition on the Company or any of
its Subsidiaries or any ERISA Affiliate (whether directly or indirectly) of (i) either a civil
penalty assessed pursuant to subsections (c), (i) or (l) of section 502 of ERISA or a Tax imposed
pursuant to Chapter 43 of Subtitle D of the Code or (ii) breach of fiduciary duty liability damages
under section 409 of ERISA.

          (d) Except as could not be reasonably be expected to result in a Material Adverse Effect, no
Plan (other than a defined contribution plan) or any trust created under any such Plan has been
terminated since the date that is six years prior to the date hereof. No liability to the PBGC
(other than for the payment of current premiums which are not past due) by the Company, any of its
Subsidiaries, or any ERISA Affiliate has been or is expected by the Company or any ERISA Affiliate
to be incurred with respect to any Plan. No ERISA Event with respect to any Plan has occurred.

          (e) Except as could not be reasonably be expected to result in a Material Adverse Effect, full
payment when due has been made of all amounts which the Company, any of its Subsidiaries, or any
ERISA Affiliate is required under the terms of each Plan or applicable law to have paid as
contributions to such Plan as of the date hereof, and no accumulated funding deficiency (as defined
in section 302 of ERISA and section 412 of the Code), whether or not waived, exists with respect to
any Plan.

          (f) Except as could not be reasonably be expected to result in a Material Adverse Effect, the
actuarial present value of the benefit liabilities under each Plan which is subject to Title IV of
ERISA does not, as of the end of the Company’s most recently ended fiscal year, exceed the current
value of the assets (computed on a plan termination basis in accordance with Title IV of ERISA) of
such Plan allocable to such benefit liabilities. The term “actuarial present value of the benefit
liabilities” shall have the meaning specified in section 4041 of ERISA.

          (g) Neither the Company, any of its Subsidiaries, nor any ERISA Affiliate sponsors, maintains,
or contributes to an employee welfare benefit plan, as defined in section 3(1) of ERISA, including,
without limitation, any such plan maintained to provide benefits to former employees of such
entities, that may not be terminated by the Company, any of its Subsidiaries, or such ERISA
Affiliate in its sole discretion at any time without any material liability.

16

 

          (h) Neither the Company, any of its Subsidiaries, nor any ERISA Affiliate sponsors, maintains
or contributes to, or has at any time in the six-year period preceding the date hereof sponsored,
maintained or contributed to, any Multiemployer Plan.

          (i) Neither the Company, any of its Subsidiaries, nor any ERISA Affiliate is required to
provide security under section 401(a)(29) of the Code due to a Plan amendment that results in an
increase in current liability for the Plan.

     5.19 Insurance. Each of the Company and each of its Subsidiaries have (a) all
insurance policies (including directors and officers liability insurance) sufficient for the
compliance by each of them with all material Governmental Requirements and all material agreements
and (b) insurance coverage in at least amounts and against such risk (including, without
limitation, public liability) that are usually insured against by companies similarly situated and
engaged in the same or a similar business for the assets and operations of the Company and each of
its Subsidiaries.

     5.20 Location of Business and Offices. The Company’s jurisdiction of organization,
its name as listed in the public records of its jurisdiction of organization and its organizational
identification number for such jurisdiction is as set forth on Schedule 4.20 hereto. The
Company’s principal place of business and chief executive offices are located at the address
specified in Exhibit A (or as set forth in a notice delivered pursuant to Section 8.8).

     5.21 Properties; Title, etc.

          (a) Each of the Company and its Subsidiaries (i) has good, marketable and defensible title to
all its Properties (excluding real property) and (ii) with respect to its real property, has good,
marketable and leasehold title, in either case, free and clear of all Liens.

          (b) All material leases and agreements necessary for the conduct of the business of the
Company and its Subsidiaries are valid and subsisting, in full force and effect, and there exists
no default or event or circumstance which with the giving of notice or the passage of time or both
would give rise to a default under any such lease or leases, which could reasonably be expected to
have a Material Adverse Effect.

          (c) The rights and Properties presently owned, leased or licensed by the Company and each of
its Subsidiaries including, without limitation, all easements and rights of way, include all rights
and Properties necessary to permit the Company and each of its Subsidiaries to conduct their
business in all material respects in the same manner as their businesses have been conducted prior
to the date hereof and as contemplated to be conducted.

          (d) All of the Properties of the Company and each of its Subsidiaries which are reasonably
necessary for the operation of their businesses are in good working condition and are maintained in
accordance with prudent business standards. All fixtures, facilities and equipment owned, leased
or held for use by the Company and that are reasonably necessary to conduct normal operations on
the Property are in a state of repair adequate to conduct such operations.

17

 

          (e) Each of the Company and each of its Subsidiaries owns, or is licensed to use, all
trademarks, tradenames, copyrights, patents and other intellectual Property material to its
business, and the use thereof by the Company and each of its Subsidiaries does not infringe upon
the rights of any other Person, except for any such infringements that, individually or in the
aggregate, could not reasonably be expected to result in a Material Adverse Effect. Each of the
Company and each of its Subsidiaries either owns or has valid licenses or other rights to use all
technical information used in their businesses as presently conducted, subject to the limitations
contained in the agreements governing the use of the same, which limitations are customary for
companies engaged in the business similar to that of the Company and each of its Subsidiaries.

     5.22 Maintenance of Properties. Except for such acts or failures to act as could not
be reasonably expected to have a Material Adverse Effect, the Properties of the Company and each
its Subsidiaries have been maintained, operated and developed in a good and workmanlike manner and
in conformity with all Governmental Requirements and in conformity with the provisions of all
contracts related to such Properties. All Property owned in whole or in part by the Company and
each of its Subsidiaries that are necessary to conduct normal operations of the Company and each of
its Subsidiaries are being maintained in a state adequate to conduct such normal operations, and
with respect to such of the foregoing which are operated by the Company and each of its
Subsidiaries, in a manner consistent with the Company’s and each its Subsidiaries’ past practices
(other than those the failure of which to maintain in accordance with this Section 4.22 could not
reasonably be expected to have a Material Adverse Effect).

     5.23 Swap Agreements. Schedule 4.23, as of the date hereof, and after the
date hereof, sets forth, a true and complete list of all Swap Agreements of the Company and each of
its Subsidiaries, the material terms thereof (including the type, term, effective date, termination
date and notional amounts or volumes), the net mark to market value thereof, all credit support
agreements relating thereto (including any margin required or supplied) and the counterparty to
each such agreement.

     5.24 Solvency. After giving effect to the transactions contemplated hereby, (a) the
aggregate assets (after giving effect to amounts that could reasonably be received by reason of
indemnity, offset, insurance or any similar arrangement), at a fair valuation, of the Company and
its Consolidated Subsidiaries, taken as a whole, will exceed the aggregate Debt of the Company and
its Consolidated Subsidiaries on a consolidated basis, as the Debt becomes absolute and matures,
(b) the Company and its Consolidated Subsidiaries, taken as a whole, will not have incurred or
intended to incur, and will not believe that it will incur, Debt beyond its ability to pay such
Debt (after taking into account the timing and amounts of cash to be received by the Company and
its Consolidated Subsidiaries and the amounts to be payable on or in respect of its liabilities,
and giving effect to amounts that could reasonably be received by reason of indemnity, offset,
insurance or any similar arrangement) as such Debt becomes absolute and matures and (c) the Company
and its Consolidated Subsidiaries will not have (and will have no reason to believe that it will
have thereafter) unreasonably small capital for the conduct of its business.

     5.25 Labor Matters.

18

 

          (a) No labor dispute with the employees of the Company or any of its Subsidiaries exists or,
to the knowledge of the Company, is imminent, that in each case could reasonably be expected to
cause a Material Adverse Effect.

          (b) Neither the Company nor any of its Subsidiaries is a party to, or bound by, any collective
bargaining agreement or any other contract with any labor union or representative of employees.

     5.26 Material Contracts and Material Liabilities. Schedule 4.26 sets forth
the material contracts and material liabilities to which the Company or any of its Subsidiaries is
a party or is bound as of the date hereof. The Company and each of its Subsidiaries are not in
breach of or in default under any material contract and have not received any written notice of
default or non-performance from the other party or any written notice of the intention of any other
party thereto to terminate or suspend any material contract.

     5.27 Foreign Asset Control Regulations, etc.

          (a) Neither the sale of the Securities by the Company hereunder nor its use of the proceeds
thereof will violate the Trading with the Enemy Act, as amended, or any of the foreign assets
control regulations of the United States Treasury Department (31 CFR, Subtitle B, Chapter V, as
amended) or any enabling legislation or executive order relating thereto.

          (b) The Company (i) is not a Person described or designated in the Specially Designated
Nationals and Blocked Persons List of the Office of Foreign Assets Control or in Section 1 of the
Anti-Terrorism Order and (ii) does not engage in any dealings or transactions with any such Person.
The Company is in compliance, in all material respects, with the USA Patriot Act.

          (c) No part of the proceeds from the sale of the Securities hereunder will be used, directly
or indirectly, by the Company for any payments to any governmental official or employee, political
party, official of a political party, candidate for political office, or anyone else acting in an
official capacity, in order to obtain, retain or direct business or obtain any improper advantage,
in violation of the United States Foreign Corrupt Practices Act of 1977, as amended, assuming in
all cases that such Act applies to the Company.

     5.28 Books and Records. All books, records and files of the Company (including those
pertaining to the Properties and other assets of the Company, and corporate, accounting, financial
and employee records): (i) since April 3, 2009, have been reasonably prepared, assembled and
maintained in accordance with usual and customary policies and procedures, except where the failure
to so maintain such materials would not reasonably be expected to have a Material Adverse Effect;
and (ii) fairly and accurately reflect the ownership, use, enjoyment and operation by the Company
of the Property and other assets.

     5.29 Affiliate Transactions. Except as disclosed on Schedule 4.29 attached
hereto, no Insider is a party to any agreement, contract, commitment or transaction currently in
effect with the Company. No Insider is a party to any agreement, contract, commitment or
transaction, other than those entered into on an arm’s-length basis, pertaining to the business of
the Company or

19

 

has any interest in any Property, real or personal or mixed, tangible or intangible, used in
or pertaining to the business of the Company that was not entered into on an arm’s length basis.

     5.30 Sufficiency of Assets. The Company, as of the Closing Date, has all of the
tangible assets, intangible assets, properties and rights that are used or held for use by it in
the operation or conduct of its business, and such assets are sufficient for the conduct of its
business immediately following the completion of the Reorganization.

     5.31 Consummation of the Reorganization. The Reorganization is being consummated
substantially concurrently with the Closing, on terms and conditions satisfactory to the Grantees.

6. REPRESENTATIONS AND WARRANTIES OF THE GRANTEES.

     Each Grantee hereby represents and warrants, severally and not jointly, to the Company as
follows as to itself (such representations and warranties do not lessen or obviate the
representations and warranties of the Company set forth in this Agreement):

     6.1 Formation; Requisite Power and Authority. Such Grantee has all necessary
corporate, limited partnership or limited liability company power and authority under all
applicable provisions of law to execute and deliver this Agreement and the Registration Rights
Agreement and to carry out their provisions. All action on such Grantee’s part required for the
lawful execution and delivery of this Agreement and the Registration Rights Agreement have been or
will be effectively taken prior to the Closing. This Agreement and the Registration Rights
Agreement have been duly executed and delivered by such Grantee and constitute the valid and
binding obligations of such Grantee, enforceable against such Grantee in accordance with their
respective terms, except (a) as limited by applicable bankruptcy, insolvency, reorganization,
moratorium or other laws of general application affecting enforcement of creditors’ rights, (b) as
limited by general principles of equity that restrict the availability of equitable remedies, and
(c) to the extent that the enforceability of the indemnification provisions of Section 6 of the
Registration Rights Agreement may be limited by applicable laws.

     6.2 Investment Representations. Such Grantee understands that neither the Securities
nor the Conversion Securities have been registered under the Securities Act. Such Grantee also
understands that the Securities are being offered and sold pursuant to an exemption from
registration contained in the Securities Act based in part upon such Grantee’s representations
contained in the Agreement. Such Grantee hereby represents and warrants as follows:

          (a) Grantee Bears Economic Risk. Such Grantee has substantial experience in
evaluating and investing in private placement transactions of securities in companies similar to
the Company so that it is capable of evaluating the merits and risks of its investment in the
Company and has the capacity to protect its own interests. Such Grantee must bear the economic
risk of this investment indefinitely unless the Securities (or the Conversion Securities) are
registered pursuant to the Securities Act, or an exemption from registration is available. Such
Grantee understands that the Company has no present intention of registering the Securities, the
Conversion Securities or any Units except pursuant to the Registration Rights Agreement. Such
Grantee also understands that there is no assurance that any exemption from

20

 

registration under the Securities Act will be available and that, even if available, such
exemption may not allow such Grantee to transfer all or any portion of the Securities or the
Conversion Securities under the circumstances, in the amounts or at the times such Grantee might
propose. Additionally, such Grantee understands that no public market exists for any of the
securities issued by the Company and that there is no assurance that a public market will ever
exist for the securities of the Company.

          (b) Acquisition for Own Account. Such Grantee is acquiring the Securities and the
Conversion Securities for such Grantee’s own account, and not with a view to distribution of the
Securities and the Conversion Securities within the meaning of Section 2(11) of the Securities Act.

          (c) Grantee Can Protect Its Interest. Such Grantee represents that by reason of its,
or of its management’s, business or financial experience, such Grantee has the capacity to protect
its own interests in connection with the transactions contemplated in this Agreement and the
Registration Rights Agreement. Further, Grantee is aware of no publication of any advertisement in
connection with the transactions contemplated in the Agreement.

          (d) Accredited Investor. Such Grantee represents that it is an accredited investor
within the meaning of Regulation D under the Securities Act.

          (e) Company Information. The Company has made available to such Grantee at a
reasonable time prior to the issuance of the Securities the opportunity to ask questions and
receive answers concerning the terms and conditions of the offering and to obtain any additional
information which the Company possesses or can be acquired without unreasonable effort or expense
that is necessary to verify the accuracy of financial information furnished by the Company.

          (f) Rule 144. Such Grantee acknowledges and agrees that the Securities, and, if
issued, the Conversion Securities must be held indefinitely unless they are subsequently registered
under the Securities Act or an exemption from such registration is available. Such Grantee has
been advised or is aware of the provisions of Rule 144 promulgated under the Securities Act as in
effect from time to time, which permits limited resale of units purchased in a private placement,
is currently not available to exempt the resale of the Securities, and if it becomes available,
will be subject to the satisfaction of certain conditions, including, among other things: the
existence of a public market for the Securities, the availability of certain current public
information about the Company, the resale occurring following the required holding period under
Rule 144 and the number of Units being sold during any three-month period not exceeding specified
limitations.

          (g) Residence. If such Grantee is an individual, then such Grantee resides in the
state or province identified in the address of such Grantee set forth on Exhibit A; if such
Grantee is a partnership, corporation, limited liability company or other entity, then the office
or offices of such Grantee in which its investment decision was made is located at the address or
addresses of such Grantee set forth on Exhibit A.

21

 

     6.3 Transfer Restrictions. Such Grantee acknowledges and agrees that the Securities
and, if issued, the Conversion Securities are subject to restrictions on transfer as set forth in
the LLC Agreement and the Registration Rights Agreement.

7. CONDITIONS TO CLOSING.

     7.1 Conditions to Grantees’ Obligations at the Closing. Each Grantee’s obligations to
be granted its portion of the Securities at the Closing are subject to the satisfaction, at or
prior to the Closing Date, of the following conditions:

          (f) Representations and Warranties True; Performance of Obligations. The
representations and warranties made by the Company in Section 4 hereof shall be true and correct in
all material respects as of the Closing Date (except that any such representations and warranties
that are qualified by materiality will be true and correct in all respects) with the same force and
effect as if they had been made as of the Closing Date, and the Company shall have performed and
complied with all obligations and conditions herein required to be performed or observed by it on
or prior to the Closing.

          (g) Legal Investment. On the Closing Date, the sale and issuance of the Securities
and the proposed issuance of the Conversion Securities shall be legally permitted by all laws and
regulations to which Grantees and the Company are subject.

          (h) Consents, Permits, and Waivers. The Company shall have obtained any and all
consents, permits and waivers necessary or appropriate for consummation of the Transactions,
including, without limitation, any material consents, permits, waivers or licenses necessary for
the Transferred Assets.

          (i) LLC Agreement. The LLC Agreement shall have been properly approved by the Board
of Directors and members of the Company and shall continue to be in full force and effect as of the
Closing Date.

          (j) Certificates. The Company shall have executed and delivered the Warrants to the
Grantees in the amounts set forth in the column labeled “Number of Warrants” on Exhibit A
attached hereto.

          (k) Corporate Documents. The Company shall have delivered to Grantees or their
respective counsel, copies of all corporate documents of the Company as Grantees shall reasonably
request.

          (l) Reservation of Conversion Securities. The Conversion Securities issuable upon
exercise of the Securities shall have been duly authorized and reserved for issuance upon such
conversion.

          (m) Compliance Certificate. If the Closing shall not have occurred on the date
hereof, the Company shall have delivered to Grantees a Compliance Certificate, executed by the
President of the Company, dated the Closing Date, certifying that all the conditions of this
Section 6.1 have been satisfied.

22

 

          (n) Secretary’s Certificate. The Grantees shall have received a certificate of the
Secretary of the Company setting forth (a) resolutions of its Board of Directors and the Investors
(as defined in the LLC Agreement) with respect to the authorization of the Company to execute and
deliver each of the Transaction Documents to which it is a party and to enter into the
Transactions, (b) the officers of the Company (i) who are authorized to sign the Transaction
Documents to which the Company is a party and (ii) who will, until replaced by another officer or
officers duly authorized for that purpose, act as its representative for the purposes of signing
documents and giving notices and other communications in connection with this Agreement and the
other Transaction Documents and the Transactions, (c) specimen signatures of such authorized
officers, and (d) the constitutive documents of the Company, including, without limitation, its LLC
Agreement, and all amendments thereto, and its Certificate of Formation, and all amendments
thereto, certified as being true and complete. Each Grantee may conclusively rely on such
certificate until such Grantee receives notice in writing from the Company to the contrary.

          (o) Transaction Documents. The Grantees’ shall have received from the Company and
each other party thereto executed counterparts (in such number as may be requested by them) of (i)
this Agreement and all schedules, exhibits and annexes hereto, (ii) the Contribution Agreement and
all schedules, exhibits and annexes thereto, (iii) the Exchange Agreement and all schedules,
exhibits and annexes thereto, (iv) each of the International Assignments, (v) each of the
International Warrants and all schedules, exhibits and annexes thereto, (vi) the LLC Agreement,
substantially in the form attached hereto as Exhibit B, and all schedules, exhibits and
annexes thereto, (vii) each of the Myriant Assignments, (viii) the Registration Rights Agreement,
substantially in the form attached hereto as Exhibit C, and all schedules, exhibits and
annexes thereto, (ix) the Transfer Agreement and all schedules, exhibits and annexes thereto, (x)
each of the Warrant Cancellation Agreements and all schedules, exhibits and annexes thereto, (xi)
each of the Warrants and all schedules, exhibits and annexes hereto and (xii) each other
Transaction Document.

          (p) Board of Directors. Upon the Closing, the authorized size and membership of the
Board of Directors of the Company shall be as set forth in the LLC Agreement.

          (q) Legal Opinion. The Grantees shall have received from legal counsel to the Company
an opinion addressed to them, dated as of the Closing Date, in a form satisfactory to the Grantees
in their sole and absolute discretion.

          (r) Tax Opinion. The Grantees shall have received from legal counsel to the Company a
tax opinion addressed to them, dated as of the Closing Date, in a form satisfactory to the Grantees
in their sole and absolute discretion.

          (s) Proceedings and Documents. All corporate and other proceedings in connection with
the Transactions and all documents and instruments incident to the Transactions shall be reasonably
satisfactory in substance and form to the Grantees and their respective counsel, and the Grantees
and their respective counsel shall have received all such counterpart originals or certified or
other copies of such documents as they may reasonably request.

23

 

          (t) Fees and Expenses. The Company shall have paid the fees and expenses set forth in
Section 8.9.

          (u) Qualifications. All authorizations, approvals or permits, if any, of any
Governmental Authority that are required in connection with the lawful issuance and sale of the
Securities and the proposed issuance of the Conversion Securities shall be obtained and effective
as of the Closing.

          (v) Officer’s Certificate. The Grantees shall have received a certificate of the
President of the Company certifying (i) that the representations and warranties of the Company in
Article 4 of this Agreement and in each other Transaction Document are true and correct in all
material respects on and as of consummation of all of the Transactions with the same effect as
though such representations and warranties had been made as of the Closing Date and (ii) no
Material Adverse Effect has occurred and is continuing as of the consummation of all of the
Transactions.

     7.2 Conditions to Obligations of the Company. The Company’s obligation to issue the
Securities at the Closing is subject to the satisfaction, on or prior to such Closing, of the
following conditions:

          (a) Representations and Warranties True. The representations and warranties made by
those Grantees acquiring Securities in Section 5 hereof shall be true and correct in all material
respects as of the Closing Date (except that any such representations and warranties that are
qualified by materiality will be true and correct in all respects), with the same force and effect
as if they had been made as of the Closing Date.

          (b) Performance of Obligations. Such Grantees shall have performed and complied with
all agreements and conditions herein required to be performed or complied with by such Grantees on
or before the Closing.

          (c) Transaction Documents. The Company shall have received from the Grantees, as
applicable, executed counterparts (in such number as may be requested by them) of (i) this
Agreement and all schedules, exhibits and annexes hereto, (ii) the Contribution Agreement and all
schedules, exhibits and annexes thereto, (iii) the Exchange Agreement and all schedules, exhibits
and annexes thereto, (iv) each of the International Assignments, (v) each of the International
Warrants and all schedules, exhibits and annexes thereto, (vi) the LLC Agreement, substantially in
the form attached hereto as Exhibit B, and all schedules, exhibits and annexes thereto,
(vii) each of the Myriant Assignments, (viii) the Registration Rights Agreement, substantially in
the form attached hereto as Exhibit C, and all schedules, exhibits and annexes thereto,
(ix) the Transfer Agreement and all schedules, exhibits and annexes thereto, (x) each of the
Warrant Cancellation Agreements and all schedules, exhibits and annexes thereto, (xi) each of the
Warrants and all schedules, exhibits and annexes hereto and (xii) each other Transaction Document.

          (d) Consents, Permits, and Waivers. The Grantees shall have obtained any and all
consents, permits and waivers necessary or appropriate for consummation of the Transactions (except
for such as may be properly obtained subsequent to the Closing).

24

 

          (e) Qualifications. All authorizations, approvals or permits, if any, of any
Governmental Authority that are required in connection with the lawful issuance and sale of the
Securities and the proposed issuance of the Conversion Securities shall be obtained and effective
as of the Closing.

8. INDEMNITY.

     The Company shall indemnify and hold each Grantee and its respective affiliates, stockholders,
partners, members, directors, officers, employees, agents, representatives and insurers (together
with such Grantee, the “Grantee Parties”) harmless from and against any and all damages
(including exemplary damages and penalties), losses, deficiencies, costs, expenses, obligations,
fines, expenditures, claims and liabilities, including reasonable counsel fees and reasonable
expenses of investigation, defending and prosecuting alleged or threatened claims from any third
party, Governmental Authority or other litigation (collectively, the “Damages”) suffered by
any of the Grantee Parties as a result of, caused by, arising out of, or in any way relating to any
breach by the Company of (i) its representations, warranties or covenants set forth in this
Agreement or in any other document delivered pursuant to or in connection herewith and (ii) the
officer’s certificate delivered to the Grantees pursuant to Section 6.1(q).

     Each Grantee shall severally, and not jointly, indemnify and hold the Company and its
affiliates, stockholders, partners, members, directors, officers, employees, agents,
representatives and insurers (together with the Company, the “Company Parties”) harmless
from and against any and all Damages suffered by the Company Parties as a result of, caused by,
arising out of, or in any way relating to any breach by such Grantee of its representations,
warranties or covenants set forth in this Agreement or in any other document delivered pursuant to
or in connection herewith.

9. MISCELLANEOUS.

     9.1 Governing Law. This Agreement shall be governed in all respects and construed and
enforced in accordance with the laws of the State of New York (excluding any conflicts-of-law rule
or principle that might refer the same to the laws of another jurisdiction), except to the extent
that the same are mandatorily subject to the laws of another jurisdiction pursuant to the laws of
such other jurisdiction.

     9.2 Survival. The representations, warranties, covenants and agreements made herein
shall survive indefinitely and the covenants of the Company will survive indefinitely.

     9.3 Successors and Assigns. Except as otherwise expressly provided herein, the
provisions hereof shall inure to the benefit of, and be binding upon, the successors, assigns,
heirs, executors and administrators of the parties hereto and shall inure to the benefit of and be
enforceable by each person who shall be a holder of the Securities from time to time.

     9.4 Entire Agreement. This Agreement, the exhibits and schedules hereto, the
Securities, the Registration Rights Agreement and the other documents delivered pursuant hereto
constitute the full and entire understanding and agreement between the parties with regard to the
subjects hereof and no party shall be liable or bound to any other in any manner by any

25

 

representations, warranties, covenants and agreements except as specifically set forth herein
and therein.

     9.5 Severability. In case any provision of the Agreement shall be invalid, illegal or
unenforceable, the validity, legality and enforceability of the remaining provisions shall not in
any way be affected or impaired thereby.

     9.6 Amendment and Waiver.

          (a) This Agreement may be amended or modified only upon the written consent of the Company and
each Grantee.

          (b) The obligations of the Company and the rights of the holders of the Securities and the
Conversion Securities under the Agreement may be waived only with the written consent of each
Grantee.

     9.7 Delays or Omissions. It is agreed that no delay or omission to exercise any
right, power or remedy accruing to any party, upon any breach, default or noncompliance by another
party under this Agreement, the Registration Rights Agreement or the LLC Agreement or any other
Transaction Document, shall impair any such right, power or remedy, nor shall it be construed to be
a waiver of any such breach, default or noncompliance, or any acquiescence therein, or of or in any
similar breach, default or noncompliance thereafter occurring. It is further agreed that any
waiver, permit, consent or approval of any kind or character on any Grantee’s part of any breach,
default or noncompliance under this Agreement, the Registration Rights Agreement or under the LLC
Agreement or any other Transaction Document or any waiver on such party’s part of any provisions or
conditions of the Agreement, the Registration Rights Agreement or the LLC Agreement or any other
Transaction Document must be in writing and shall be effective only to the extent specifically set
forth in such writing. All remedies, either under this Agreement, the Registration Rights
Agreement, the LLC Agreement or any other Transaction Document, by-laws, or otherwise afforded to
any party, shall be cumulative and not alternative.

     9.8 Notices. All notices and communications required or permitted hereunder shall be
in writing and shall be deemed effectively given: (a) upon personal delivery to the party to be
notified, (b) when sent by confirmed facsimile, (c) when sent by registered or certified mail,
return receipt requested, postage prepaid, or (d) one (1) when sent with a nationally recognized
overnight courier, specifying next day delivery, with written verification of receipt. All notices
and communications shall be sent to the Company at the address as set forth on the signature page
hereof and to any Grantee at the address set forth on Exhibit A attached hereto or at such
other address as the Company or such Grantee may designate by ten (10) days advance written notice
to the other parties hereto.

     9.9 Expenses. The Company shall pay all costs and expenses that it incurs with
respect to the negotiation, execution, delivery and performance of the Agreement; provided,
however, that the Company shall, at the Closing, reimburse the reasonable fees of and expenses of
Vinson & Elkins LLP.

26

 

     9.10 Attorneys’ Fees. In the event that any suit or action is instituted to enforce
any provision in this Agreement, the prevailing party in such dispute shall be entitled to recover
from the losing party all fees, costs and expenses of enforcing any right of such prevailing party
under or with respect to this Agreement, including without limitation, such reasonable fees and
expenses of attorneys and accountants, which shall include, without limitation, all fees, costs and
expenses of appeals.

     9.11 Titles and Subtitles. The titles of the sections and subsections of the
Agreement are for convenience of reference only and are not to be considered in construing this
Agreement.

     9.12 Counterparts. This Agreement may be executed in any number of counterparts, each
of which shall be an original, but all of which together shall constitute one instrument. Delivery
of an executed counterpart of a signature page of this Agreement by telecopy shall be effective as
delivery of a manually-executed counterpart of this Agreement.

     9.13 Broker’s Fees. Each party (the “Paying Party”) hereto represents and
warrants that no agent, broker, investment banker, person or firm acting on behalf of or under the
authority of the Paying Party is or will be entitled to any broker’s or finder’s fee or any other
commission directly or indirectly in connection with the transactions contemplated herein that will
be payable by any party other than the Paying Party. Each Grantee agrees to indemnify and to hold
harmless the Company and each other Grantee from any liability for any commission or compensation
in the nature of a finder’s fee arising out of this transaction (and the costs and expenses of
defending against such liability or asserted liability) for which such Grantee or any of its
officers, employees, or representatives is responsible. The Company agrees to indemnify and hold
harmless each Grantee from any liability for any commission or compensation in the nature of a
finder’s or broker’s fee arising out of this transaction (and the costs and expenses of defending
against such liability or asserted liability) for which the Company or any of its officers,
employees or representatives is responsible.

     9.14 Exculpation Among Grantees. Each Grantee acknowledges that it is not relying
upon any person, firm, or corporation, other than the Company and its officers and directors, in
making its investment or decision to invest in the Company. Each Grantee agrees that no Grantee
nor the respective controlling persons, officers, directors, members, partners, agents, or
employees of such Grantee shall be liable to any other Grantee for any action heretofore or
hereafter taken or omitted to be taken by any of them in connection with the Securities and
Conversion Securities.

     9.15 Confidentiality. (a) Each party hereto agrees that, except with the prior
written consent of the Relevant Party, it shall at all times keep confidential and not divulge,
furnish or make accessible to anyone any confidential information, knowledge or data concerning or
relating to the business or financial affairs of any other parties (the “Relevant Party”)
to which such party has been or shall become privy by reason of this Agreement, the Registration
Rights Agreement or other Transaction Documents, discussions or negotiations relating to this
Agreement, the Registration Rights Agreement or any other Transaction Document, the performance of
its obligations hereunder or the ownership of the Securities issued hereunder. The provisions of
this Section 8.15 shall be in addition to, and not in substitution for, the provisions of any
separate nondisclosure agreement executed by the parties hereto.

27

 

          (a) Notwithstanding any provision of this Agreement, nothing contained in this Agreement shall
prevent any party from disclosing all or any portion of confidential information of a Relevant
Party:

     (i) upon the request or demand of any regulatory agency or authority
having or claiming jurisdiction over such party;

     (ii) to the extent reasonably required in connection with any
litigation to which such party is a party;

     (iii) upon the order of any court or administrative agency; or

     (iv) as may otherwise be required by law.

          (b) In the event of any disclosure pursuant to this Section 8.15, such party will provide the
Relevant Party with prompt notice (unless prohibited by law) so that the Relevant Party may seek a
protective order or other appropriate remedy. In the event that such a protective order or other
protective remedy is not obtained, such party will furnish only that portion of the confidential
information of the Relevant Party (a) that is requested or demanded in the case of disclosure
pursuant to subsection (i), (b) that is required in the case of disclosure pursuant to subsection
(ii) or (c) that is legally required in the opinion of its counsel in the case of disclosure
pursuant to subsection (iii) and (iv) above.

     9.16 Pronouns. All pronouns contained herein, and any variations thereof, shall be
deemed to refer to the masculine, feminine or neutral, singular or plural, as to the identity of
the parties hereto may require.

[Signature Pages Follow]

28

 

     IN WITNESS WHEREOF, the parties hereto have executed this Agreement as of the date set forth
in the first paragraph hereof.

	 	 	 	 	 	 	 

	 	 	COMPANY:	 	 
	 
	 	 	 	 	 	 
	 	 	MYRIANT TECHNOLOGIES LLC	 	 
	 
	 	 	 	 	 	 
	 

	 	By:	 	 	 	 
	 

	 	Name:
	 	 

Stephen J. Gatto
	 	 
	 

	 	Title:
	 	President	 	 

[Signature Page to Warrant Issuance Agreement]

 

 

	 	 	 	 	 	 	 

	 	 	GRANTEES:	 	 
	 
	 	 	 	 	 	 
	 	 	PLAINFIELD FINANCE CORPORATION	 	 
	 
	 	 	 	 	 	 
	 

	 	By:	 	 	 	 
	 

	 	Name:
	 	 

Steven Segaloff
	 	 
	 

	 	Title:
	 	Authorized Agent	 	 

[Signature Page to Warrant Issuance Agreement]

 

 

	 	 	 	 	 	 	 

	 	 	CAMULOS BIOENERGY PARTNERS LLC	 	 
	 
	 	 	 	 	 	 
	 

	 	By:	 	 	 	 
	 

	 	Name:
	 	 

Michael Iuliano
	 	 
	 

	 	Title:
	 	General Counsel	 	 

[Signature Page to Warrant Issuance Agreement]

 

 

	 	 	 	 	 	 	 

	 	 	ITERA ETHANOL, LLC	 	 
	 
	 	 	 	 	 	 
	 

	 	By:	 	 	 	 
	 

	 	Name:
	 	 

Steven Sisselman
	 	 
	 

	 	Title:
	 	President and Chief Operating Officer	 	 

[Signature Page to Warrant Issuance Agreement]

 

 

	 	 	 	 	 	 	 

	 	 	NGP CAPITAL RESOURCES COMPANY	 	 
	 
	 	 	 	 	 	 
	 

	 	By:	 	 	 	 
	 

	 	Name:
	 	 

	 	 
	 

	 	Title:
	 	 

	 	 
	 

	 	 	 	 

	 	 

[Signature Page to Warrant Issuance Agreement]

 

 

LIST OF EXHIBITS

	 	 	 

	Schedule of Grantees

	 	Exhibit A
	 
	 	 
	Limited Liability Company Agreement

	 	Exhibit B
	 
	 	 
	Registration Rights Agreement

	 	Exhibit C
	 
	 	 
	Form of Warrant

	 	Exhibit D
	 
	 	 
	BioEnergy Group Reorganization Authority Steps Memo

	 	Exhibit E

 

 

EXHIBIT A

SCHEDULE OF GRANTEES

	 	 	 	 	 	 	 	 	 	 	 
	 	 	 	 	Number of	 	Number of
	Investor Name	 	Address	 	Units	 	Warrants
	Plainfield Finance Corporation
	 	Plainfield Finance Corp.
	 	 	0	 	 	 	2,114,355	 
	 
	 	c/o Plainfield Asset
	 	 	 	 	 	 	 	 
	 
	 	Management LLC
	 	 	 	 	 	 	 	 
	 
	 	55 Railroad Avenue
	 	 	 	 	 	 	 	 
	 
	 	Greenwich, CT 06830
	 	 	 	 	 	 	 	 
	 
	 	Attention:  Thomas X. Fritsch
	 	 	 	 	 	 	 	 
	 
	 	Fax: (203) 302-1779	 	 	 	 	 	 	 	 
	 
	 	 	 	 	 	 	 	 	 	 
	Camulos BioEnergy Partners LLC
	 	3 Landmark Square, 4th Floor
	 	 	0	 	 	 	884,534	 
	 
	 	Stamford, CT 06901	 	 	 	 	 	 	 	 
	 
	 	 	 	 	 	 	 	 	 	 
	Itera Ethanol, LLC
	 	9995 Gate Parkway N.
	 	 	0	 	 	 	243,798	 
	 
	 	Suite 400
	 	 	 	 	 	 	 	 
	 
	 	Jacksonville, Florida 32246
	 	 	 	 	 	 	 	 
	 
	 	Tel: 904-996-8800
	 	 	 	 	 	 	 	 
	 
	 	Fax: 904-996-8805	 	 	 	 	 	 	 	 
	 
	 	 	 	 	 	 	 	 	 	 
	NGP Capital Resources Company
	 	1221 McKinney Street
	 	 	0	 	 	 	507,313	 
	 
	 	Suite 2975
	 	 	 	 	 	 	 	 
	 
	 	Houston, TX 77010	 	 	 	 	 	 	 	 

 

 

EXHIBIT B

LIMITED LIABILITY COMPANY AGREEMENT

 

 

EXHIBIT C

REGISTRATION RIGHTS AGREEMENT

 

 

EXHIBIT D

FORM OF WARRANT

 

 

EXHIBIT E

BIOENERGY GROUP REORGANIZATION AUTHORITY STEPS MEMO

 

 

SCHEDULE OF EXCEPTIONS

 

 

Schedule 5.2

Changes

None.

 

 

Schedule 5.6

Approvals; No Conflicts

None.

 

 

Schedule 5.7

Material Debt

	•	 	Ten Million Dollar ($10,000,000) secured promissory note accruing interest at six percent
(6%) per annum by and between BioEnergy International, LLC and BioEnergy Holding LLC, dated
August 15, 2007

 

 

Schedule 5.8

Litigation and other Governmental Proceedings

None.

 

 

Schedule 5.12

Insurance

None.

 

 

Schedule 5.14

Swap Agreements

None.exv10w31

Exhibit 10.31

SCIENTIFIC ADVISORY PANEL AGREEMENT

THIS SCIENTIFIC ADVISORY PANEL AGREEMENT (the “Agreement”), dated as of _______________, by
and between Myriant Technologies, LLC (the “Company”), a Delaware limited liability company
with offices at 1 Pinehill Drive, Two Batterymarch Park, Suite 301, Quincy, Massachusetts 02169,
and ________________ (the “Advisor”), with an address at ______________________.

WITNESSETH

     WHEREAS, the charter for which is attached as Charter Exhibit A, to advise the Board of
Directors and management of the Company as to the technology, business, organizational development,
policy and outreach related to proprietary cellulosic technology and patented microbial
fermentation, including the strategy of commercializing biorefineries with biocatalysts that
convert low-cost sugars into targeted, high value renewable biochemicals and biofuels, and make
non-binding recommendations to the Board of Directors and management of the Company;

     WHEREAS, the Advisor has experience, capabilities and knowledge that qualify the Advisor to
serve on the Scientific Advisory Panel; and

     WHEREAS, the Company seeks advisory services from the Advisor, and the Advisor seeks to
provide such services to the Company under the terms and conditions contained herein.

     NOW, THEREFORE, in consideration of the Agreement set forth herein, the parties hereby agree
as follows:

1. Appointment. The Company hereby appoints the Advisor to the Scientific Advisory Panel,
and the Advisor hereby agrees to provide the services described herein.

2. Services. The Advisor shall provide advisory services to the Company, from time to time
at the Company’s request, which advisory services may include, but shall not be limited to the
following:

	 	(a)	 	Consulting with the Company within the Advisor’s professional area of
expertise;
	 
	 	(b)	 	Soliciting input from others within the Advisor’s professional area of
expertise;
	 
	 	(c)	 	Exchanging strategic and business development ideas with the Company; and
	 
	 	(d)	 	Participating in Scientific Advisory Panel meetings, such meetings to take
place at times and locations to be determined, and often in conjunction with the Board
of Directors meetings;

 

     The 2010 Schedule is as follows:

     April 19th, University of Pennsylvania hosted by Professor Benkovic

     July 22nd, University of Illinois hosted by Professor Zhao

     October — UFRFI, hosted by Professor Ingram. Date has not been confirmed

     December 10th — Myriant Technologies, Date is tentative.

3. Term and Termination. This Agreement shall become effective on the date hereof and shall
remain in force for a term of three (3) years. This Agreement shall be renewable for additional
three (3) year terms, at the invitation of the Company and the acceptance of the Advisor.
Furthermore, this Agreement may be terminated, in writing, by either the Company or the Advisor, at
any time and for any reason.

4. Compensation. Upon execution of the Agreement, the Advisor will receive compensation of
restricted stock having an initial value of Twenty Five Thousand Dollars (US $25,000) and every
year thereafter during their term as long as the company is an LLC. Upon establishment of the
proposed C-corporation as the parent of the Company, the annual stipend thereafter will consist of
a value of Twenty Five Thousand Dollar (US $25,000) to be comprised of (a) sixty percent (60%) of
equity in the parent company; and forty percent (40%) in cash. In addition, the Advisor shall
receive Two Thousand Dollars ($2000) per meeting day for attendance at any of the Scientific
Advisory Panel meetings.

5. Expenses. The Advisor shall be entitled to reimbursement from the Company for all
reasonable out-of-pocket expenses incurred in connection with its services to the Scientific
Advisory Panel, upon presentation to the Company of written documentation for such expenses.

6. Inventions. Advisor agrees to disclose in writing to the Company all inventions,
improvements and other innovations related to the development and commercialization of
biorefineries for the production of high-value bio-based chemicals and fuels from renewable
feedstock through the use of its proprietary biocatalyst technology that Advisor may make or
conceive in the course of serving a member of the Company’s Scientific Advisory Panel, if they are
related to his or her scientific and business work for the Company and whether or not they are
eligible for patent, copyright, trademark, trade secret or other legal protection
(“Innovations”). Advisor hereby assigns all her rights in the Innovations to the Company.
At the Company’s request and expense, during and after the period of Advisor’s consulting
arrangements with the Company, Advisor agrees to assist and cooperate with the Company in all
respects and will execute documents, and, subject to his or her reasonable availability, give
testimony and take further acts requested by the Company to obtain for the Company, maintain and
enforce patent, copyright, trademark, trade secrets and other legal protection for the Innovations.

7. Confidential Information. The Advisor acknowledges that the Advisor may be furnished or
given access to certain non-public information of commercial or other value to the business in
which the Company is engaged (the “Confidential Information”) during the term of this
appointment. The Advisor further acknowledges that Confidential Information constitutes a

 

proprietary right that the Company is entitled to protect. Accordingly, the Advisor agrees that
during the term of this Agreement and thereafter until such time as all the Confidential
Information becomes publicly known and made generally available through no action or inaction of
the Advisor, the Advisor will keep in strict confidence the Confidential Information and shall not,
without prior written consent of the Company in each instance, disclose, use or otherwise
disseminate the Confidential Information, directly or indirectly, to any third party.

8. Indemnification. The Advisor shall have no obligations or liabilities, other than those
identified in Sections 6 and 7 herein, for any actions or omissions taken as an Advisor. Any
Advisor who is made, or threatened to be made, a party to any pending action or proceeding, whether
civil, criminal, administrative or investigative, arising out of or related to the Advisor’s
service on the Scientific Advisory Panel, shall be indemnified by the Company and the Company shall
advance to the Advisor such related expenses incurred in defense of such action to the fullest
extent permitted by applicable law. The Company shall make any indemnification payment, including
any payment of defense costs, promptly after request by Advisor. For the purposes hereof, Advisor
shall include such Advisor’s heirs and personal representatives. The Company further acknowledges
that the foregoing indemnification is a material inducement for the Advisor to serve on the
Scientific Advisory Panel and that the Advisor would not otherwise agree to serve on the Scientific
Advisory Panel in the absence of this inducement. This Section 8 shall survive the termination of
this Agreement.

     IN WITNESS WHEREOF, the parties hereto have executed this Agreement as of the date hereof.

Myriant Technologies, LLC

	 	 	 	 	 

	By:
	 	 	 	 
	 

	 	 

	 	 
	 
	 	 	 	 
	[Advisor]	 	 
	 
	 	 	 	 
	By:

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00191-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00191-of-00352.parquet"}]]